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Abstract
Although smooth muscle cells participate in the remodeling associated with
atherosclerosis and other vascular diseases, the mechanisms by which these cells interact
with their mechanical environment are incompletely characterized. This thesis serves to
elucidate the capacity of smooth muscle cells to modulate their matrix and respond to
mechanical loading.
Because integrins mediate many cell-matrix interactions, the role of integrins in
reorganization and mechanical contraction of collagen by smooth muscle cells was
assessed in blocking antibody studies. Of the collagen-specific integrins (a(11, c2 p1, and
CI31) found to be expressed by these cells, only the ct• and a2 integrins mediated smooth
muscle cell adhesion to collagen. In addition collagen gel contraction was mediated by a 2,
but not by ao or a3 integrins. Interestingly, gel contraction was inhibited by an anti-031
antibody known for its stimulatory effect on cell adhesion.
To evaluate the mechanical regulation of smooth muscle cell function in a three-
dimensional matrix, collagen gel cultures were subjected to uniaxial, unconfined
compression. Sustained static compression led to a decrease in DNA and
glycosaminoglycan synthesis, respectively, as measured by 3H-thymidine and 35S-sulfate
incorporation. Decreased incorporation was not due to diffusive limitation of the
radiolabel into the gel. A brief transient compression led to a delayed induction of DNA
synthesis but a decrease in glycosaminoglycan synthesis. The induction of DNA synthesis
increased with the compressive gel strain, and was mediated by autocrine release of FGF-2
as demonstrated by antibody-blocking studies and ELISA. Thus mechanical loading
differentially regulates metabolic functions of smooth muscle cells in a three-dimensional
culture.
Cellular strain was hypothesized to control the release of FGF-2 from smooth
muscle cells; however, these strains cannot be readily assessed theoretically or
experimentally from the bulk gel strain. Thus, a second method which imposes
homogeneous and biaxially uniform strains to monolayer cells was developed. Oscillatory
strain induced FGF-2 release dependent on the amplitude (0-30%), frequency (0 - 1 Hz),
and number of cycles of strain (0 - 10'). There was a strain amplitude-threshold (10%)
below which FGF-2 was not released. Above this threshold, FGF-2 release increased with
the frequency, amplitude, and cycle number, but was maximally released by only -102
cycles of strain. Thus cellular strain amplitude and/or strain rate tightly regulate the
release of FGF-2 from vascular smooth muscle cells. In addition, heparin studies
demonstrated that cellular strain causes a transfer of intracellular FGF-2 to the
extracellular low-affinity receptors.
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Introduction
Mechanical forces regulate the functions of various cells including osteocytes,1-4
chondrocytes, s'6 fibroblasts, 7-9 cardiac 10-14 and skeletal'5 '16 myocytes, and endothelial
cells.1'7' 9 This thesis serves to assess relationships between vascular smooth muscle cells
and their mechanical environment. The experimental results may lend insight to general
mechanisms of cellular responses to mechanical stimuli but may be particularly relevant to
vascular physiology and disease.
1.1 Atherosclerosis
Atherosclerosis, a chronic disease affecting the intimal layer of medium- and large-
sized arteries, is the principal etiology of myocardial and cerebral infarction and the
leading cause of mortality in the U.S., and other developed countries. 20 The atherosclerotic
lesion may begin early in life as an intimal aggregation of lipid-rich macrophages and T-
lymphocytes, the "fatty streak", and may evolve over many years to a more advanced lesion or
plaque.21  Although several classifications have been defined, plaques are typically
characterized by hyperplastic smooth muscle cells and foam cells, abundant dense extracellular
matrix, and deposits of lipid and cholesterol.20 In an atherosclerotic coronary artery, a raised
plaque may stenose the lumen and chronically obstruct the supply of blood to the myocardium,
resulting in stable angina. Acutely, the surface of the plaque may rupture, potentially leading
to thrombosis.22 Although plaque rupture may occur frequently during the evolution of
coronary lesions and without clinical symptoms, plaque rupture occasionally leads to occlusive
thrombi and is probably the primary mechanism underlying acute coronary syndromes.21' 23-25
Experiments with hypercholesterolemic animals demonstrate a sequence of vas-
cular changes consistent with human postmortem pathology and provide the basis for the
"response-to-injury" model of atherogenesis, first proposed by Glomset and Ross in 1976.
In this model, injury to the endothelium leads to an excessive fibro-proliferative
inflammatory response beginning with 1) adhesion of inflammatory cells, including
monocytes and T lymphocytes, to the endothelium, and followed by 2) migration of these
cells into the vessel wall, 3) migration of vascular smooth muscle cells from the media into
the intima, 4) proliferation of vascular smooth muscle cells and macrophages, 5)
sequestration of lipid by macrophages and subsequent foam cell formation 6) excessive
accumulation of extracellular matrix and 7) deposition of lipid and cholesterol in the
matrix.20 These activities are coordinated by biochemical, and perhaps mechanical,
interactions among smooth muscle cells, endothelial cells, monocytes and macrophages,
T-lymphocytes, platelets, and the extracellular matrix. 20,26
1.2 The Vascular Smooth Muscle Cell
Besides regulating short-term vascular tone myogenically, smooth muscle cells
participate in vascular remodeling by synthesizing and secreting extracellular matrix,
matrix-degradative enzymes, and also growth factors and other cytokines (Figure 1.1).
Vascular smooth muscle cells produce much of the extracellular matrix in the vessel wall.
Serving both structural and biological functions, these matrix components include
collagens which provide tensile stiffness, elastin which confers properties of elastic recoil,
and proteoglycans which help regulate permeability and visco-elasticity, cell adhesion and
migration,27 and also low-density lipoprotein accumulation and foam cell formation. 28-30
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Figure 1.1 The role of smooth muscle cells in vascular remodeling. Smooth muscle cells synthesize
extracellular matrix and degradative enzymes, and also secrete growth factors and other cytokines which
can act in autocrine or paracrine fashions. Certain growth factors can bind to extracellular matrix and are
subsequently released by matrix degradative enzymes.
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Vascular smooth muscle cells also synthesize and secrete matrix degradative
enzymes. Smooth muscle cells can digest extracellular matrix using both plasminogen-
dependent and plasminogen-independent proteinases.31 Stromelysin mRNA has been
detected in human atherosclerotic lesions,32 and expression of activated members of all
three matrix metalloproteinase classes is increased in vulnerable regions of atherosclerotic
tissue.33 Vascular remodeling mediated by the synthesis and degradation of matrix
components may be important for migration of smooth muscle cells34 and other cells,
lesion progression and regression,"35 and plaque structural properties such as failure
strength.36,37
In addition, smooth muscle cells coordinate cellular functions by synthesizing and
secreting growth factors and other cytokines, which act in autocrine or paracrine fashion.26
Matrix metabolism can be regulated by smooth muscle cell-derived cytokines. Collagen
synthesis may be modulated by transforming growth factor-3 (TGF-p) 38 and interleukin-l
(IL-1);39 in turn, the synthesis of interstitial collagenase40 and stromelysin,41 respectively,
may be induced by platelet-derived growth factor (PDGF) and IL-1. Smooth muscle cell
proliferation may also be regulated by TGF-P, PDGF, and fibroblast growth factor-2
(FGF-2).42,43 Macrophage recruitment may be mediated by chemotactic factors such as
monocyte chemoattractant protein-i (MCP-1).44
1.3 Mechanical Forces in Blood Vessels
Blood vessels are continously exposed to various mechanical loads (Figure 1.2),
including pressure and shear forces exerted on the lumen, and resultant tensile,
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compressive, and torsional forces borne within the wall. A primary hypothesis of this
thesis is that cellular deformation, or strain, as a result of these loads, regulates cellular
function. The distribution of mechanical stress in the vessel, as in any structure, is
dependent on both the loads and certain structural parameters, such as geometry and
constitutive material properties. These physical parameters may vary widely between and
within vessels, depending on the structural organization of cells, extracellular matrix, and
any lipid or calcified regions. To understand the potential effect of externally applied
loads on the internal structure, it is useful to consider a simple general case. Under
quasistatic mechanical loading, the resulting deformations within a heterogeneous
structure composed of linear elastic materials may be discretely modeled. The
deformations, [U], are related to the loads, [R] (applied, as well as reactions due to
boundary conditions) by the equilibrium equation
[K][U]= [R] (1.1)
where [K] is the global stiffness matrix formulated from the stiffnesses of the individual
structural elements. The internal strains [e] may be derived from the displacements [U]
through an appropriate strain-displacement interpolation transformation. The internal
stresses, [t], are then obtained from the strains [e] by
[r]= [C]le] (1.2)
where [C] is the matrix of elasticity also derived from the stiffness matrix and the strain-
displacement transformation. The addition of dynamic loading, in general, would
introduce additional inertial and damping terms; however, these equations reveal that for a
given loading condition, local strains may vary widely within a heterogeneous structure.
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Figure 1.2 Mechanical loads associated with a segment of blood vessel. Applied forces (normal (A) and
shear (B) forces intraluminally and (C) normal forces externally) give rise to reaction forces (normal (D)
and shear (E) forces internally).
For example, under physiological conditions, the externally applied fluid shear
stress and pressure, respectively, range from 0 to 102 Pa 45 and from 103 to 104 Pa. The
resultant internal stresses may range from 0 to 10' Pa. From the above equations, strains
may vary widely and within a small region because they are related to the loads through a
matrix of elemental compliances. In the vascular wall, material compliance can vary by
two or three orders of magnitude depending on the density and organization of collagen
and proteoglycan fibrils. Furthermore, still greater heterogeneity exists in the local vicinity
of a single cell; at that level, cells and matrix fibrils are discrete elements which form a
structure similar to an engineering truss; as is the case for truss elements under a given
loading condition, individual cells may experience dramatically different strains depending
on their location and orientation within the mechanically loaded tissue. Thus, the
deformation of an individual cell cannot be generally determined from the loading
condition, the general shape of the tissue, and the overall global stiffness. In the biological
literature, the terms "stress" and "strain" are sometimes used interchangeably to refer to
many different types of mechanical stimuli. However, in this thesis, different terms are
used to describe, with varying degrees of specificity, a mechanical stimulus. Mechanical
"loading" or "deformation" are used to refer to a general mechanical stimulus. The terms
"stress" or "strain", respectively, are used to refer to a mechanical load in which the
average bulk stress (force/area) or strain (change in length/initial length) is controlled.
Finally, the term "cellular strain" is reserved to refer to a mechanical load in which strain
at the cellular level is regulated.
1.4 Evidence for Vascular Responses to Mechanical Loading
The modulation of vascular biology by mechanical loading has been observed at
several levels. Clinically, the medial hypertrophy of hypertension 46,47 and restenosis
associated with percutaneous transluminal coronary angioplasty4"'49 suggest adaptive
vascular remodeling in response to mechanical forces and/or cell injury. Finite element
analytical studies on actual human atherosclerotic lesions demonstrate a correlation
between mechanical stress concentrations and locations of plaque rupture.37 Specific
cellular responses are revealed by in vivo and in vitro studies.
1.4.1 In Vivo Studies
The anatomical sites of initiation and progression of atherosclerosis have been
shown to correlate with locations of low-magnitude oscillatory fluid shear stress.50 In
addition, an endothelial-dependent negative-feedback process appears to control long-
term vessel wall structure to maintain shear stress magnitude at 15 dyne/cm 2.51
Coarctation and congenital models of hypertension reveal increased proteoglycan
synthesis by arterial smooth muscle cells.52,53
1.4.2 In Vitro Studies
Previous in vitro studies have demonstrated responses to mechanical loading both
in endothelial and smooth muscle cells. The endothelium, by virtue of its location at the
interface between vessel wall and blood flow, is subjected to fluid shear stress as well as
internal wall stresses and appears to act as a mediator in regulating arterial diameter both
acutely and chronically. 54 Fluid shear stress applied to cultured endothelial cells leads to
changes in cell topography, 5s cell shape,56 pinocytosis," alignment, 58'59 cytoskeletal
architecture, and in the expression of genes. These changes include a down-regulation of
endothelin-160 (ET-1) and thrombomodulin, 61 as well as an induction of FGF-2,62 tissue
plasminogen activator,63 TGFO3-1, and PDGF A and B. Furthermore, the PDGF B gene
has been shown to be regulated by a cis-acting shear-stress-responsive element in its
promoter64 and shear stress has been shown to stimulate DNA binding activities of nuclear
factor kappa B and nuclear factor activator protein-i (AP-1). 6 5
Endothelial cell responses may be tightly controlled by specific components of the
stress. In endothelial cells, pinocytotic rates are dependent on the frequency of shear
stress imposed.57 Shear stress regulation of PDGF-B, FGF-2, and endothelin-1 in
endothelial cells is magnitude- and frequency-dependent.62'66 In addition, the regulation of
proliferation by fluid shear stress is observed with turbulent67 but not with laminar shear
stress61 of comparable magnitude.
In contrast to what is known about the endothelial cell, regulation of vascular
smooth muscle cell function by mechanical loading is less well understood. Previous
experiments have been performed primarily in monolayer culture.68 Rat,69 bovine,59 and
porcine 70 aortic vascular smooth muscle cells cultured on elastic substrates and subjected
to cyclic deformation tend to align perpendicularly to the direction of membrane strain. In
similar experiments, changes in cellular proliferation and DNA synthesis have been
demonstrated. Although DNA synthesis is decreased in porcine aortic vascular smooth
muscle cells subjected to oscillatory loading of 0.05 Hz, synthesis is increased in neonatal
rat71 and in human saphenous vein vascular smooth muscle cells72 deformed at a frequency
of 1 Hz. On the other hand, deformation applied at 1 Hz did not alter growth of rabbit
aortic," human internal mammary artery, 72 and rat and lamb pulmonary arterial smooth
muscle cells.73 Mechanical deformation of smooth muscle cells has also been shown to
increase 68 '74 or decrease73 collagen synthesis, increase proteoglycan synthesis,6" and
increase"6 or decrease73 general protein synthesis. In addition, static deformation of
porcine aortic smooth muscle cells increases elastin synthesis." The diversity of
responses in these studies suggests that cellular responses may depend not only on the
type, species, and anatomical origin of the cell, but also on the characteristics of the
mechanical loading.
1.5 Limitations of Previous Studies
1. 5. 1 Response in a Three-dimensional Matrix
Although the ability of mechanical loading to alter smooth muscle function in a
monolayer configuration has been demonstrated, the effect of mechanical deformation on
cells in a three-dimensional matrix culture has not been completely characterized. Cells
adhere to their surrounding matrix through integrins, heterodimeric transmembrane
receptors. Integrins bind to specific amino acid sequences of extracellular matrix
constituents.76 Integrin cytoplasmic domains are physically associated with cytoskeletal
components which interlink with microfilaments76 and participate in bi-directional
communication between the cell and matrix.
Integrins can transmit various forces exerted by cells upon their extracellular
matrix. Cell migration is mediated by force generation via distinct a subunit cytoplasmic
domains.77 Dermal fibroblasts exert measurable forces78 which mediate collagen gel
contraction and reorganization. Although human vascular smooth muscle cells have also
been shown to contract collagen matrices,79 the role of specific integrins in gel contraction
has not been characterized. Several a subunits associate with 31 subunits to mediate
adhesion of rat vascular smooth muscle cells to fibronectin, laminin, and collagen.80
Adhesion of lamb ductus arteriosus vascular smooth muscle cells to fibronectin, laminin,
and collagens type I and IV is dependent on 131 integrins, while migration over these
substrates is heavily dependent on the ovb3 integrin. •
Integrins can also transmit external forces to the cell cytoskeleton, 82 inducing
changes in cell shape which may regulate growth and differentiation. 3 However, the
ability of mechanical loading to regulate cellular function in a three-dimensional matrix is
incompletely understood. Cells in a three-dimensional matrix behave differently from
those in monolayer configuration.84 'ss Collagen matrix can regulate cell phenotype and
morphology, 86,87 collagen 38,88 and proteoglycan synthesis, and also collagenase gene
expression. 89,90 In addition, proliferation of cells 91-93 and responsiveness to soluble
growth factors may be decreased by contact with a three-dimensional matrix. 94
1.5.2 Relationship between Cellular Strain and Function.
In most previous studies, cells adhered to an elastic membrane substrate have been
deformed at a controlled frequency of oscillation but with an uncontrolled, spatially
nonuniform strain profile. Under these conditions, both strain amplitude and strain rate
depend on the cell's location on the membrane (see Chapter 6 Discussion); thus, the
frequency of mechanical loading in these experiments specifies only a general stimulus
intensity. Given the close regulation of endothelial function by fluid shear stress, smooth
muscle cell function may also depend on specific mechanical features such as cellular
stress (or strain) amplitude or rate. The ability to control these features might be critical
for interpreting certain cellular responses to mechanical loading.
1.6 Objectives
The objective of this thesis was to further characterize some of the functional
relationships between vascular smooth muscle cells and their mechanical environment.
The thesis is divided into two general parts, each addressing one limitation discussed in
Section 1.5. The first part addresses mechanical relationships between the smooth muscle
cell and its three-dimensional matrix; global stress or strain is applied in a controlled
fashion to the three-dimensional matrix, but no attempt is made to control these
parameters at the cellular level. The second part (Chapters 5 and 6) of the thesis focuses
on the role of cellular strain in responses to mechanical loading; here methods to control
cellular strain are used, but the potential role of the three-dimensional matrix is de-
emphasized.
1.7 Primary Hypotheses
* Specific integrins participate in vascular smooth muscle cell contraction and
reorganization of their matrix. In Chapter 2, a subset of integrins mediating
smooth muscle cell adhesion to collagen is found to participate in collagen gel
contraction; however, increased adhesion through one integrin adversely affects
collagen contraction.
* Static mechanical compression regulates DNA and matrix synthesis by
vascular smooth muscle cells. In Chapter 3, the smooth muscle cell-collagen gel
is used to evaluate the regulation of DNA and glycosaminoglycan synthesis by
mechanical compression. Static, unconfined compression is found to decrease
biosynthesis, but transient compression leads to a differential response -- increased
DNA synthesis and decreased glycosaminoglycan synthesis. In Chapter 4, the
DNA synthetic induction by a single transient matrix compression is found to be
mediated by autocrine FGF-2.
Cellular strain tightly controls cellular function. In Chapter 5, the rationale for
controlling cellular strain rather than a bulk tissue stress is discussed in further
detail. A previously used prototype cell strain device is modified, built, and
experimentally verified to impose homogeneous and equi-biaxial strain to cells on
an elastic membrane. Preliminary experiments demonstrate cellular strain-
controlled release of FGF-2 and IL-la, respectively, from smooth muscle cells and
keratinocytes. In Chapter 6, the control of FGF-2 release by cellular strain is
further assessed. Strain amplitude and/or strain rate appear to regulate both cell
injury and FGF-2 release.
Chapter
2
Collagen Matrix Contraction and Reorganization by
Human Vascular Smooth Muscle Cells: Role of Integrins
2.1 Abstract
Vascular smooth muscle cells perform the important function of modulation of
vascular extracellular matrix. Because integrins mediate many cell-matrix interactions, the
role of integrins in reorganization of collagen by cultured human vascular smooth muscle
cells was studied. Immunoprecipitation demonstrated that human vascular smooth muscle
cells express multiple 01 integrins. Monoclonal antibody IIE10 (a blocking anti-a 2
antibody) inhibited adhesion of smooth muscle cells to collagen by 31%. The blocking
anti-a' antibody 1B3.1 inhibited adhesion by 40%, while a blocking anti-a 3 antibody had
no effect on adhesion. When 1B3.1 and IIE10 were both used, a 79% reduction in
adhesion was observed, indicating that active a' and a 2 integrins cooperatively mediate
adhesion. The blocking anti-i0 antibody Mabl3 abolished smooth muscle cell-mediated
gel contraction, and the a 2 blocking antibody IIE10 had a dose-dependent partial
inhibitory effect (37%). In contrast, blocking antibodies to a' and a3 had no effect. When
anti-a' (1B3.1) and anti-a 2 (IIEO1) monoclonal antibodies were combined, no synergistic
effect on inhibition of gel contraction was observed. Surprisingly, collagen gel contraction
was inhibited by 46% by an anti-Pi antibody (TS2/16) known for its stimulatory effect on
cell adhesion. Thus, while a'•1 and a 201 integrins both participate in adhesion of vascular
smooth muscle cells to collagen, only 2f31 integrins mediate collagen reorganization. In
addition, collagen reorganization appears to be a dynamic process, adversely affected by
excessive adhesion strengthening.
2.2 Introduction
Vascular smooth muscle cells perform many functions that are critical for
determining--vascular structure during development, normal homeostasis, and disease
states. In response to mechanical stimuli, smooth muscle cells change orientation, growth
state, and extracellular matrix synthesis, permitting homeostatic adaptations to the
pulsatile stresses of blood pressure.71'95 In addition, vascular smooth muscle cells migrate
into the intima, proliferate, and secrete the extracellular matrix of atherosclerotic
lesions.9 "'97 These lesions typically contain a collagen matrix that is relatively dense
compared with the normal vessel. This collagenous matrix is, in part, responsible for
changes in the biomechanical behavior of the vessel that can lead to instability and,
ultimately, fracture of the lesion with thrombosis and occlusion. 21'
98
Studies of fibroblasts, melanocytes, and other cells cultured in hydrated collagen
lattices have demonstrated that mammalian cells will contract and reorganize collagen
fibrils.99-'0' This process of physically contracting collagen is analogous to the
organization of collagen matrix that occurs in dermal wound healing and development of
normal connective tissues and is mediated by integrins.99' °0' Integrins are heterodimeric
cell surface receptors for extracellular matrix molecules that can transduce mechanical
signals from the extracellular environment into the cell.76,102,103  The integrin family
includes at least 15 ca subunits and 8 [3 subunits that can form 21 different heterodimers,
and three different a subunits (a', a 2, and a3 ) can form complexes with the 31 subunit and
function as collagen receptors. In addition to ligand specificity, integrins may have cell-
type specific differences in function. For example, the a2 13 integrin may function as a
collagen receptor on fibroblasts or a collagen and laminin receptor on other cells.10 4,105
The a2 01 integrin appears to mediate collagen gel contraction, and this process has been
implicated in the pathophysiology of vitreoretinal contraction and retinal detachment. 10 6,'0 7
Collagen gel contraction by a 2J1 integrins can be abolished by exchange of the
cytoplasmic domain of the a2 subunit with that of the a4 subunit with no effect on
adhesion to collagen.77  Thus, integrins function as more than adhesion receptors for
extracellular matrix.
A variety of integrins on cultured vascular smooth muscle cells have been
described. Clyman et al described several a subunits associated with f1 subunits that
mediated adhesion of rat vascular smooth muscle cells to fibronectin, laminin, and
collagen.80 ,'08 Lamb ductus arteriosus smooth muscle cells have 01 integrins that appear to
mediate adhesion to fibronectin, laminin, and collagens type I and IV, while migration of
these cells on these substrates is heavily dependent on a133 integrins.8  Because integrins
may play an important role in smooth muscle cell regulation of vascular structure, we
studied integrin-mediated extracellular matrix reorganization by cultured human vascular
smooth muscle cells. We found that a'13 and a201 integrins both participated in
mediating adhesion to collagen, while a 2 13 integrins mediated collagen gel contraction,
demonstrating specificity of a subunit functions in human vascular smooth muscle cells. In
addition, we report that collagen gel contraction can be inhibited by an anti-31, integrin
antibody that usually stimulates adhesion, suggesting that dynamic conformational changes
in i3 integrins are necessary for collagen reorganization.
2.3 Materials and Methods
2.3.1 Monoclonal Antibodies.
Monoclonal antibodies used (Table 2.1) included Mabl3 (anti-01) and Mabl6
(anti-a 5),'09 1B3.1 (anti-a'),"O 12F1 (anti-a 2),"' P3 (nonspecific control),112 TS2/7 (anti-
a'),"3 B5G10 (anti-a 4), 4 TS2/16 (anti-01) 5"-17 and P1H5 (anti-a 2).'0' Additional
monoclonal antibodies used that were developed and characterized in the laboratory of M.
Hemler include IIE10 and 3E9 (both anti-a 2), 6.7 (anti-as), and A6-ELE (anti-a 6).
Monoclonal antibody IA3 (anti-a3) was developed and characterized by F. Berdichevsky
and J. Taylor-Papadimitriou.
Table 2.1. Monoclonal antibodies against
**TS2/16 is stimulatory.
integrins. *Ability to block cell adhesion to integrin ligand.
2.3.2 Cell Preparation and Culture
Smooth muscle cells were cultured by explant out-growth from unused portions of
human saphenous veins from coronary bypass surgery by a protocol approved by the
Brigham and Women's Hospital Human Research Committee. The cell cultures were
grown in Dulbecco's modified Eagle's medium (DMEM) (M.A. Bioproducts, Walkersville,
MD) with 10% fetal calf serum (FCS). All tissue culture constituents were selected for
low endotoxin levels (<40 pg/ml) by Limulus amoebocyte lysate assay (QCL 1000, M.A.
Bioproducts). Experiments were performed at passage 4 or 5 following harvesting.
ANTIGENS ANTIBODY BLOCKING?*
a1  TS2/7 No
1B3.1 Yes
a 2  3E9 No
IIE10 Yes
P1H5 Yes
a3  IA3 Yes
c4  B5G10 No
(a 6.7 ?
Mabl6 Yes
a 6  A6-ELE No
P1 Mabl3 Yes
TS2/16 **No
2.3.3 Immunoprecipitation.
Cultured human smooth muscle cells were detached from tissue culture plastic
with 2mM EDTA and surface labelled with Na' 251 using lactoperoxidase and glucose
oxidase as previously described. s8  Cellular proteins were solubilized in the
immunoprecipitation buffer (1% of NP-40, 50mM Tris HCI, pH 7.5, 150 mM NaCI, 5mM
MgCl2, 2mM PMSF, 20glg/ml aprotinin, 20jig/ml leupeptin) for 1 hour at 40C and the
protein extract was incubated with appropriate monoclonal antibodies for 1 hour at 40C.
Immune complexes were recovered on Protein A-Sepharose beads preabsorbed with
rabbit anti-mouse polyclonal antisera and washed five times with immunoprecipitation
buffer. Immunoprecipitated proteins were eluted from the Protein A-Sepharose beads in
Laemmli loading buffer and resolved in 8.5% SDS/polyacrylamide gels. The dried gels
were exposed for 24 hours at -700C with X-OMAT film (Kodak, Rochester, NY).
2.3.4 Cell Adhesion Assays.
96-well plates were coated overnight with a solution of collagen type I (5gtg/ml),
blocked with 0.1% heat-denatured bovine serum albumin (hdBSA) for 45 min at 370C,
and washed twice with phosphate-buffered saline. Cells were detached from the tissue
culture plastic with 2mM EDTA, washed with phosphate-buffered saline, and labelled with
the fluorescent dye BCECF-AM (2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein)
(Molecular Probes, Inc., Eugene, OR) for 30 min at 370C. After labelling, the cells were
washed twice with phosphate-buffered saline, resuspended in 0.1% hdBSA/RPMI and
preincubated with appropriate antibodies for 30 min at 40C before addition to the matrix
coated plate (50.000 cells per well). After incubation for 25-30 min at 370 C, the plates
were washed three times with RPMI to remove nonadherent cells. The fluorescence
before and after washes was evaluated with a CytoFluor 2300 fluorescent analyzer
machine (Millipore Co., Bedford, MA). Every measurement point was performed in
triplicate, and adhesion was estimated as a number of attached cells per mm2.
2.3.5 Collagen Gel Contraction.
Cell culture in hydrated collagen gels was performed with Vitrogen 100 collagen
(Collagen Corp, Palo Alto, CA) as previously described.99 Vascular smooth muscle cells
were preincubated with monoclonal antibodies at various concentrations for 30 min and
then diluted 10 fold to yield final gel concentrations. The preincubated cells were then
added to neutralized collagen (2.5 mg/ml) at a concentration of 2 X 105 cells/ml. The
collagen-cell suspensions (1.5 ml each) were then incubated in 24 well plates (Costar,
Cambridge, MA) at 37°C for one hour to polymerize the collagen, and the gel was then
gently cut away from the sides of the well and lifted off the bottom. At selected time
points, the diameter of the hydrated gels was measured using an inverted microscope.
2.4 Results
2.4.1 Immunoprecipitation and Adhesion to Collagen.
To study the role of integrins in reorganization of collagenous matrix by human
vascular smooth muscle cells, we first analyzed their integrin profile by
immunoprecipitation using specific monoclonal antibodies (Figure 2.1). Vascular smooth
muscle cells express abundant levels of several integrins of the 31 family (lanes 1-6),
including a'•I3, a2 1, aO•1, and S13i, whereas the cell surface expression of Oa43 1was low
and a6p1 was almost undetectable. An anti-13 antibody precipitated all of the 01-
containing integrins at once (lane 7).
Figure 2. 1. Integrin expression in cultured human vascular smooth muscle cells. Cells were surface-
labelled with Na'l2I, lysed in 1% Brij 96 extraction buffer and immunoprecipitated with specific
monoclonal antibodies against different integrin subunits. Immunoprecipitates were resolved by SDS-
PAGE and autoradiography. The anti-integrin antibodies were: lane 1. TS2/7 (anti-oa): lane 2. IIE10
(anti-oi); lane 3. IA3 (anti-o ); lane 4, B5G (anti-a4): lane 5. mAB 16 (anti-or); lane 6. A6-ELE (anti-o 6):
lane 7. mAB13 (anti-fJ1): lane 8. P3-nonspecific control.
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To explore the role of these integrins in adhesion of vascular smooth muscle cells
to collagen type I, adhesion experiments were performed in the presence of specific
blocking monoclonal antibodies (Figure 2.2). Monoclonal antibodies P1H5 and IIE10
(which block C2-mediated adhesion) reduced adhesion by 34% and 31%, respectively,
and the anti-a' blocking antibody 1B3.1 reduced adhesion by 40%. However, when
1B3.1 and IIE 10 were both used, adhesion was reduced by 79%, indicating that these cells
use both al3 1 and a C2 1 integrins to interact with collagen. Accordingly, monoclonal
antibody Mabl3 (which blocks the function of all 01 integrins) reduced adhesion .to
collagen by 95%. In parallel experiments, blocking anti-a3 3 1 or non-blocking anti-a'l•
and anti-23•i monoclonal antibodies did not block adhesion (data not shown). Notably,
adhesion to collagen was not increased by TS2/16, presumably because adhesion is
already at a near maximal level.
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antibodies for 30 min at 40C and allowed to attach to the adhesion surface for 30 min at 37nC. Non-
adherent cells were removed in three consecutive washes and the attachment was analyzed using
CytoFluor 2300. P3 is a control non-integrin antibody. IB3.1 is an inhibitory anti-aO 13 antibody, PIH5
and IIE10 are inhibitory anti-a2p1 antibodies, Mabl3 is an inhibitory anti-0 1 antibody, and TS2/16 is an
anti-P3I antibody known to stimulate adhesion. Error bars denote one standard deviation.
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2.4.2 Collagen Gel Contraction.
When human vascular smooth muscle cells were cultured in floating hydrated
collagen gels, the gels contracted in a highly reproducible and symmetric manner.
Signficant reduction in gel diameter occurred within the first 24 hr, and contraction was
essentially complete after 72 hours. To evaluate the role of collagen-binding integrins in
this process, collagen gel contraction experiments were performed in the presence of
blocking anti-integrin monoclonal antibodies. The anti-a 2 blocking antibody IIE10 had a
dose-dependent partial inhibitory effect on gel contraction (37% at 72 hr, Figure 2.3A),
while the non-blocking anti-a 2 3E9 antibody had no inhibitory effect (Figure 2.3B). The
anti-a 2 blocking antibody PlH5 also inhibited gel contraction by 40% at 72 hr (data not
shown). In contrast, the presence of blocking antibodies to a' (Figure 2.4A) and a3
(Figure 2.4B) had no effect on collagen gel contraction. Moreover, in contrast with the
results of the adhesion experiments, when anti-a' (1B3.1) and anti-a 2 (IIE10) antibodies
were combined, no synergistic effect on inhibition of gel contraction was observed (Figure
2.5). The 31 -blocking antibody Mabl3 abolished smooth muscle cell-mediated gel
contraction (Figure 2.3A, 3B), but in all experiments, IIElO and P1H5 failed to inhibit gel
contraction as effectively as Mabl3. Although the anti-0J antibody TS2/16 had no
inhibitory effect on cell adhesion, it strongly inhibited collagen gel contraction in a dose-
dependent manner, with 46% inhibition (at 72 hr) for the highest dose (Figure 2.6). The
maximal inhibitory effect of TS2/16 was less than that observed with Mabl3 (86%), but
similar to the inhibitory effects of blocking anti-a 2 antibodies (37-40%).
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Figure 2.3. Effect of inhibition of (02p1 function on contraction of collagen matrices by vascular smooth
muscle cells. O are Mabl3, 1 ug/ml, and A are without antibody. A. Effect of antibody IIE10. B. Effect
of antibody 3E9. In both panels A and B, 0 represent antibody diluted 1:500, * are 1:100,; V are 1:20,
and 0 are 1:10 dilutions of monoclonal antibody culture supernatants. Points are average of duplicate
matrices.
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Figure 2.4. Effect of inhibition of o p~ or dapi function on contraction of collagen matrices by vascular
smooth muscle cells. O are Mabl3, 1 jLg/ml, and A are without antibody. A. Effect of antibody IB3.1 in
concentrations of 1:2500, 1:500, and 1:250 as dilutions of ascites fluid. B. Effect of antibody IA3 in
concentrations of 0.2, 2.0, and 20 ug/ml. Points are average of duplicate matrices.
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Figure 2.5. Effect of inhibition of a'& and oaPj function on contraction of collagen matrices by vascular
smooth muscle cells. Open A are without antibody. U are with 1:100 dilution of antibody 1B3.1 ascites
fluid. 0 are with 1:20 dilution of antibody IIE10 culture supernatant. Open V are with both 1B3.1 and
IIE10. Means and standard deviations of triplicates are shown.
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Figure 2.6. Effect of stimulating anti-01 antibody TS2/16 on contraction of collagen matrices by vascular
smooth muscle cells. V are Mabl3, 1 Rg/ml, and A are in the absence of antibody. * are 1:5000, 0 are
1:2000, and O are 1:500 dilutions of ascites fluid. Points are average of triplicate matrices.
2.5 Discussion
In this study, we found that function-blocking antibodies to individual a subunits
of collagen-binding integrins partially blocked vascular smooth muscle cell adhesion, while
the combination of antibodies to both a' and a2 subunits markedly inhibited adhesion. It
is not surprising that a cell responsible for regulating structure in a collagenous matrix
both acutely through active contraction and chronically through organization of matrix
should have a redundant system for adhering to collagen. On the other hand, the addition
of antibodies blocking act function did not lead to additional inhibition of collagen gel
contraction over the a2 blocking antibody, indicating that in the collagen reorganization
process, integrins function as more than simply collagen adhesion receptors. In this
regard, it was previously shown that replacement of the a2 cytoplasmic domain with that
of a4 did not alter adhesion to collagen, but did abolish gel contraction."
The complexity of the collagen reorganization process was further demonstrated
by the effects of the stimulatory monoclonal antibody TS2/16. The TS2/16 antibody can
increase adhesion in cells with 01 integrins that are not fully active, presumably by
inducing a conformational change that causes increased ligand binding. The results of this
study indicate that f3 integrins of cultured vascular smooth muscle are already in a highly
active state, since adhesion was not increased by TS2/16. Although the stimulatory
antibody had minimal effect on adhesion, collagen gel contraction was markedly inhibited.
One potential explanation for this finding is a dynamic mechanism of collagen
reorganization that requires: 1) integrin-mediated adhesion to collagen, 2) contraction
through cytoskeletal force generation, and 3) subsequent release of collagen from the
integrin. The integrin could then bind to new collagen ligands, and the contraction
process would begin again. This dynamic adhesion and release mechanism may be similar
to proposed mechanisms of integrin-mediated cell migration." 9 Indeed, it was recently
demonstrated that the stimulatory antibody 8A2 inhibited migration, presumably by
freezing eosinophil 01 integrins in the high-avidity adhesion state. 120
Previous studies have identified a• 321 integrins as the primary mediators of the gel
contraction phenomenon.99"0 ' However, as seen in previous studies,10 ' antibodies
blocking a2 function failed to achieve the magnitude of inhibition of collagen gel
contraction of Mabl3 in this study. Although we observed this incomplete inhibition with
two different a2 function-blocking antibodies (IIE10 and P1H5), it is possible that Mabl3
has a much higher potency for blocking integrin function than the other antibodies.
The ability of cells to contract and organize collagen is fundamental in the wound
healing process. Dermal fibroblasts have been shown to generate measurable traction
forces during collagen gel contraction 78 which in vivo may serve to close a skin wound
and increase the strength of the loose granulation tissue, ultimately forming a strong scar.
Atherosclerosis resembles the wound healing process in many ways. 20 In response to a
variety of stimuli, smooth muscle cells migrate into the intima and secrete extracellular
matrix rich in collagen and proteoglycans.21 It is likely that smooth muscle cells
participate in organizing the collagen in this newly-synthesized matrix to form the dense
network of collagen that is often seen in the advanced atheroma. The organized collagen
network is one reason that atherosclerotic tissue is several times stiffer than the normal
vessel wall. 121 Studies of vascular mechanics suggest that this difference in stiffness may
predispose the vessel to plaque rupture and thrombosis by establishing regions of high
stress near the junction of the stiffer plaque with the more normal vessel.37
It is important to recognize that cultured human vascular smooth muscle cells are
phenotypically different from smooth muscle cells in vivo. 122'12 Previous reports have
suggested that the profile of integrins on vascular smooth muscle cells changes in cell
culture. Koteliansky et al found that expression of a' integrins by human aortic smooth
muscle cells decreased during subculturing;' 24 in addition, smooth muscle cells from
thickened intima of human adult aorta express five times less c' than cells from adult
aortic media. 125  Vascular smooth muscle cells cultured in collagen gels have some
differences compared to cells grown on plastic; for example, smooth muscle cells reduce
collagen synthesis and are less responsive to growth factors.94,126 Although we have not
observed changes in integrin profile between smooth muscle cells grown on plastic or
grown in collagen gels (preliminary studies not shown), Klein et al have found that a 2J1
integrins in some cells are upregulated by growth in collagen gels.99 It is also possible that
integrin activation state could be changed by culture in the collagen lattice.
In conclusion, this chapter serves to identify a potential mechanism used by
vascular smooth muscle cells in vivo to mechanically contract and organize extracellular
matrix, and opens the way for further studies to determine how modulating ca201 function
might change vessel wall structure. In addition, these experiments indicate that the
process of collagen reorganization by cells has stringent biological and mechanical
requirements; it does not occur if adhesion to collagen is mediated by the wrong integrin
(i.e. c'011 ) or if adhesion is excessively strong (i.e. in the presence of TS2/16). In the
remaining chapters, the capacity of the mechanical environment to control cellular function
is discussed.
Chapter
3
Biosynthetic Response to Compression of the Three-
Dimensional Matrix Culture
3.1 Abstract
The appropriate control of smooth muscle cell proliferation and extracellular
matrix metabolism may be essential for maintaining the normal vascular state. Mechanical
stimuli have been shown previously to regulate these functions in vascular smooth muscle
cells grown in monolayer configuration. However, the effects of mechanical loading on
smooth muscle cells in a three-dimensional matrix have been incompletely characterized.
The purpose of this study was to evaluate the potential regulation of DNA and
glycosaminoglycan synthesis by compression of a smooth muscle cell-collagen gel culture.
Static, unconfined compression inhibited 3H-thymidine incorporation; compression for 24
hrs at 0.25, 1.0 and 2.5 kPa stress, respectively, led to incorporations of 475 + 200, 86 +
7, and 64 + 17 cpm/gel (vs. 1000 + 220 cpm/gel for control, p < 0.05 by ANOVA).
Compression also decreased 35S-sulfate incorporation; 24 hr of compression at 0.25, 1.0
and 2.5 kPa, respectively, led to incorporations of 230 + 30, 200 + 8 and 211 + 33
cpm/gel (vs. 460 + 40 cpm/gel for control, p < 0.05). Decreased incorporation of
radiolabel was not due to diffusional limitation by compression; there was no difference in
total gel 3H-thymidine concentration after 24 hr of compression at 10, 50, 250, or 1000
kPa. In addition, 3H-thymidine incorporation decreased linearly with the magnitude of
compressive gel strain, suggesting that biosynthesis was controlled by the matrix
deformation rather than the applied force. Decreased DNA synthesis was reversible after
release of compression. In addition, transient compression led to a delayed induction of
3H-thymidine incorporation; at 24-48 hr after compression (5 min., 50% strain) and
release, incorporation was 3000 + 620 cpm/gel (vs. 990 + 100 cpm/gel for control, p <
0.005). Thus, mechanical loading of smooth muscle cells in a three-dimensional matrix
regulates DNA and glycosaminoglycan synthesis.
3.2 Introduction
The dysregulation of cellular proliferation, migration, and extracellular matrix
metabolism may contribute to vascular disease states.127-129 Interactions among smooth
muscle cells, macrophages, endothelial cells, platelets, and other cells as well as the
extracellular matrix are coordinated by growth factors and other cytokines. 20,130,131 In
addition to biochemical signals, mechanical forces may participate in proliferative and
remodeling responses. In vivo studies suggest that elevated intravascular pressures may
accelerate the medial hypertrophy and decreased vascular compliance often associated
with hypertension. 46,132 The mechanical stress imposed during balloon angioplasty may
trigger some of the early cellular responses of restenosis. 133,134
Vascular smooth muscle cells synthesize many of the extracellular matrix
components in the vessel wall. 13s Besides synthesizing five of the six types of collagen
found in blood vessels' 36, smooth muscle cells also make the large proteoglycan versican
as well as the small proteoglycans, decorin and biglycan. Both chondroitin sulfate and
dermatan sulfate proteoglycans accumulate in atherosclerotic tissues, and may promote
low-density lipoprotein accumulation and oxidation, and also foam cell formation.28-30
Proteoglycan synthesis by smooth muscle cells may be regulated by PDGF and TGF-P13'
as well as the extracellular matrix.138
Mechanical loading has been shown to regulate vascular smooth muscle cell
proliferation and matrix synthesis, primarily in monolayer culture. Oscillatory forces
induce the proliferation of neonatal rat71 and human saphenous vein 72 smooth muscle
cells, but decrease the proliferation of porcine aortic smooth muscle cells.7 ° Other studies
with human mammary artery,72 and also rat and lamb pulmonary arterial smooth muscle
cells,73 reveal no growth effect by mechanical stimuli. Mechanical loading may also
increase 68,74 or decrease73 collagen production, and increase proteoglycan synthesis.68 The
apparent diversity of responses in these studies may reflect differences both in the species
and anatomical origin of the cells as well as in the specific loading protocols used.
Although these studies demonstrate sensitivity of smooth muscle cells to the
mechanical environment, 139 the regulation of vascular smooth muscle cells in a three-
dimensional matrix has not been characterized. Cells grown in a three-dimensional lattice
behave differently from those in monolayer. Collagen matrix affects vascular smooth
muscle cell ultrastructure, proliferation, and synthesis of collagen and proteoglycans.
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In lattice culture, the vascular smooth muscle cell assumes a spindle shape similar to that
observed in vivo and proliferates more slowly than in monolayer.'41 The cellular response
to mechanical forces may be mediated by certain cytoskeletal compression- and tension-
bearing elements oriented in a three-dimensional configuration. 142 Thus, in this chapter,
smooth muscle cell-collagen matrix culture were subjected to compression, and DNA and
glycosaminoglycan synthesis was measured.
3.3 Materials and Methods
3.3.1 Cell Culture .
Human vascular smooth muscle cells were derived from explants of discarded
portions of saphenous veins obtained during coronary bypass surgery performed at
Brigham and Women's Hospital. Monolayer smooth muscle cells were cultured in
Dulbecco's Modified Eagle Medium (DMEM) (Whittaker Bioproducts, Inc.) with 10%
fetal calf serum (FCS), at 370 C and 5% CO2. These conditions are selective for growth of
smooth muscle cells over endothelial cells.143 The explant and culture techniques were
identical to protocols used in previous studies of cultured vascular smooth muscle
cells. 39,14 4 ,14 5 Cells were cultured through passages 3 - 5 prior to transfer to a three-
dimensional collagen gel culture system for use in compression experiments.
Cell culture in hydrated collagen gels was performed with Vitrogen 100 collagen
(Celtrix Pharmaceutical) as previously described.' 46  Cells (2.5 - 3.0 x 105) were
suspended in 1.25 ml collagen (2.8 mg/ml) and cultured in standard 24-well (16 mm
diam.) culture plates (Costar Corporation). Gel cultures were maintained in DMEM
supplemented with 10% FCS and 0.07 mM ascorbate-2-phosphate (Wako Pure Chemical
Industries) and received a change of culture medium every two days. The contraction of
collagen gel matrices by these cells may be resisted by local adhesions to the culture plate
wells; thus, to facilitate uniform, axisymmetric gel contraction, on day 5 the gel cultures
were gently detached from the sides of the wells. Over the course of 10 days in culture,
smooth muscle cell-gels contracted uniformly to disks with nearly identical dimensions in a
given experiment; the standard deviation of gel thicknesses, measured by micrometer prior
to compression, was less than 5% of the mean. Final contracted gel diameter ranged from
4.5 - 7.0 mm, and thickness ranged from 1.0 - 2.5 mm in different experiments.
3.3.2 Mechanical Compression.
In 24-well plates (Costar), smooth muscle cell-collagen gel cultures were mounted
between porous (nominal pore size 40-60 um, Porex), polyethylene platens to permit
diffusion into the gel during compression (Figure 3.1). Static uniaxial, unconfined
compression was applied with load-control by manually lowering a cylindrical weight onto the
top platen. This configuration of loading was used to qualitatively simulate radial compressive
and circumferential tensile deformations in the pressurized blood vessel (Figure 3.2). In some
experiments, a Teflon spacer was inserted between the platens to control the displacement of
compression.
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Figure 3.1. Static compression of vascular smooth muscle cell-collagen gel in a well of a standard 24-well
culture plate. Gel is mounted between two porous polyethylene platens and compressed by a cylindrical
weight. Alternatively, teflon spacers are inserted between platens to control gel compressive
displacement.Figure 3.2. Vessel wall under internal pressure, P. Unconfined gel compression in this
study simulates radial compressive and circumferential tensile deformations indicated on element.
Figure 3.2. Vessel wall under intraluminal pressure, P. Unconfined gel compression in this study
simulates radial (r) compressive and circumferential (0) tensile deformations indicated on element.
3.3.3 Equilibrium Stress-Strain Relation of Gel Culture.
Smooth muscle cell-collagen gel cultures were loaded in a polysulfone,
cylindrically unconfining chamber which was mounted in a servo-controlled Dynastat
mechanical spectrometer (IMASS, Hingham, MA). The gel cultures were compressed in
displacement control between the porous polyethylene platens in DMEM supplemented
with 10% FCS; the initial gel thickness was determined by micrometer before the gel was
loaded. Gel cultures were compressed by sequential increments of 10% strain, estimated
as the vertical displacement divided by the initial thickness, up to a maximum of -90%
strain. At each displacement, the load was recorded after a stress relaxation period. The
stress was estimated as the load normalized to the initial area of the gel face (Figure 3.3)
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Figure 3.3. Equilibrium stress-strain relationship for smooth muscle cell-collagen gel under unconfined
compression (displacement control). Stress represents the compressive load normalized to the initial gel-
platen contact area. Strain represents the decrease in gel thickness normalized to the initial gel thickness.
3.3.4 3H-Thymidine Incorporation.
Smooth muscle cell-collagen gel cultures were pulse-labeled with methyl-[3H]-
thymidine, 6.7 mCi/mmol, (Dupont-NEN) to measure DNA synthesis. Following
radiolabeling, smooth muscle cell-collagen gel matrices were solubilized overnight in 4
mol/L urea, 0.5% sodium dodecyl sulfate (SDS), and precipitated with 10%
trichloroacetic acid at 40 C. Precipitates were vacuum-collected on 0.45 gm filters
(Millipore Corp.) and washed with 10% trichloroacetic acid at 40 C. Filters were air-
dried, mixed with Ecolume (ICN Biomedicals) scintillation cocktail, and counted with a
scintillation counter (Pharmacia LKB Nuclear). To assess nonspecific radiolabeling of the
gel matrices, parallel smooth muscle cell-gel cultures in some experiments were subjected
to three cycles of freezing at -800 C and thawing at 370 C prior to radiolabeling. The
nonspecific counts were generally less than 5% of those in the live smooth muscle cell-gel
cultures.
3.3.5 35S-Sulfate Incorporation.
Smooth muscle cell-collagen gel cultures were pulse-labeled with "3S-sulfate (25
gpCi/ml) to measure glycosaminoglycan synthesis. After radiolabeling, culture media were
collected, and gels were washed six times in PBS at 40 C; wash fractions were pooled with
the media. Following lyophilization, gels were digested in papain (0.25 mg/ml) at 600 C.
Sephadex G-25 M (Pharmacia PD-10) gel-filtration chromatography was performed on
gel digests and media/washes to assess the incorporation of 35S-sulfate into
macromolecules greater than 1-5 kDa. Samples were dissolved and eluted with 4 mol / L
Guanidine-HCI running buffer. Total 35S-sulfate incorporation (combined gel, media, and
wash) was determined for each gel sample by scintillation counting of the macromolecular
fractions and adjusting for background cpm.
3.3.6 Total Radiolabel in GeL
Following pulse-labeling, gels were solubilized in 4 mol / L urea, 0.5 % SDS, and
total 3H-thymidine or 35S-sulfate in aliquots were determined by scintillation counting.
3.3.7 Measurement of Total DNA Content
Smooth muscle cell-gel cultures were frozen, lyophilized, and digested in 1 ml/gel
papain (Sigma, 125 mg/ml) for 24 hours at 600 C. Hoechst 33258 dye solution was added
to digest aliquots in an acrylic cuvet, and DNA content was measured fluorometrically,
using calf thymus DNA as a standard. 147
3.3.8 Measurement of Glycosaminoglycans.
Smooth muscle cell-gel cultures were frozen, lyophilized, and digested in 1 ml/gel
papain (Sigma, 125 mg/ml) for 24 hours at 600 C. Aliquots of gel digests were mixed with
dimethylmethylene blue dye in flat-bottom 96-well plates (Nunc), and glycosaminoglycan
content was measured spectrophotometrically, using chondroitin-6-sulfate (Sigma) in
Vitrogen as a standard.
3.3.9 Statistics.
Data are presented as mean + one standard deviation (or + one standard error of
mean) for n = 3 or 4 measurements. For comparison among several groups of continous
variables, analysis of variance was used. For comparison between specific groups of
continuous variables, the two-sample Student's t test was used. A p value < 0.05 was
considered statistically significant.
3.4 Results
3.4.1 Effect of Static Compression on Biosynthesis.
Static compression of vascular smooth muscle cell-collagen gel cultures decreased
3H-thymidine incorporation in a stress-dependent fashion (Figure 3.4). Compression for
24 hr of 0, 0.25, 1.0 and 2.5 kPa stress, respectively, led to incorporations of 1000 + 220,
480 + 200, 90 + 10, and 60 + 20 cpm/gel (p < 0.05 by ANOVA). Static compression also
decreased 35S-sulfate incorporation (Figure 3.5); compression of 0, 0.25, 1.0, and 2.5 kPa
stress, respectively, led to incorporations of 460 + 40, 230 + 30, 200 + 10, and 210 + 30
cpm / gel. Total DNA and glycosaminoglycan in the gel cultures did not change during
the 24 hr compressions (data not shown).
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Figure 3.4. 3H-thymidine incorporation by human vascular smooth muscle cells in collagen gel culture
during 24 hr static compression (load control). Stress represents the compressive load normalized to the
initial gel-platen contact area. Data represent mean + sem for n=3 or 4.
-
100 -
90 -
E
e 80 -
+1
E 70 -
50 -360-
N 30
20 -
10
0.0 0.5 1.0 1.5 2.0 2.5
stress (kPa)
Figure 3.5. 35S-sulfate incorporation by human vascular smooth muscle cells in collagen gel culture
during 24 hr static compression. Stress represents the compressive load normalized to the initial gel-
platen contact area. Data represent mean + sem for n=3 or 4.
3.4.2 Diffusion of Thymidine.
To assess whether decreased radiolabel incorporation was caused simply by limited
radiolabel diffusion into the compressed gel, total 3H-thymidine in the gel was measured
during compression. Although 3H-thymidine equilibrated in the gel within - 60 min. after
· · · · ·
pulse-labeling, the absolute amount of radiolabel in the gel decreased with the compressive
stress (Figure 3.6); after 24 hr of compression at 0, 10, 50, 250, and 1000 Pa, respectively,
gels contained 1150 + 30, 760 + 34, 550 + 45, 260 + 7, and 250 + 3 cpm total 3H-
thymidine. A similar experiment was performed to evaluate whether the reduction in total
radiolabel in the gel was associated with decreased gel volume; after 24 hr compression,
3H-thymidine (Figure 3.7A) and gel wet weight (Figure 3.7B) decreased similarly with the
applied stress. The effective concentration of radiolabel, estimated as the total gel 3H-
thymidine normalized to the gel wet weight, did not decrease with the compressive stress
(Figure 3.8); after 24 hr of compression at 0, 10, 50, 250, and 1000 kPa, respectively, the
average total 3H-thymidine concentration in the gel was 7890, 7880 + 1350, 7570 + 340,
7090 + 1980, and 5780 + 1200 (p = NS). Thus, gel compression was not associated with
decreased radiolabel concentration.
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Figure 3.6. Time course of total (incorporated + unincorporated) 3H-thymidine in smooth muscle cell-
collagen gel cultures during sustained static compression of 10 (0), 50 (U), 250 (C), and 1000 Pa (V)
stress applied at time 0, relative to control (0). Data represent mean + sd for n=3.
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Figure 3.7. (A) Total (incorporated + unincorporated) 3H-thymidine in smooth muscle cell-collagen gel
cultures after 24 hr compression and radiolabeling. (B) Wet weight of the gels after 24 hr compression.
Data represent mean + sd for n= 1 to 3.
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Figure 3.8. Total 3H-thymidine in gel normalized to gel wet weight after 24 hr static compression and
radiolabeling. Data represent mean + sd for n=l to 3.
3.4.3 Dependence of DNA Synthesis on Static Compressive Strain.
The stress (1 kPa) required to completely inhibit DNA synthesis was much lower
than normal mean intravascular pressures, but was sufficient to impose large (> 50%) gel
strains. Thus, we assessed the change in DNA synthesis with compression in
displacement-control. Compressive strain of 0%, 20%, 27%, 40%, 47%, 60%, and 80%,
respectively, led to incorporations of 880 + 58, 690 + 39, 680 + 300, 417 + 130, 403 +
340, 140 + 154, and 130 + 113 cpm/gel (p < 0.05 by ANOVA, Figure 3.8).
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Figure 3.9. 3H-thymidine incorporation by vascular smooth muscle cell in collagen gel culture during 24
hr static compression (displacement control). Gel strain represents the decrease in gel thickness
normalized to the initial thickness. Data represent mean + sd for n = 3.
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3.4.4 Effect of Release of Compression.
To evaluate whether the compression-induced decrease in biosynthesis was
reversible, gel cultures were either compressed and pulse-labeled for 24 hours, or
compressed for 24 hours, released from compression, and pulse-labeled for the
subsequent 24 hours. Compression decreased 3H-thymidine incorporation in a strain-
dependent manner, and subsequent release of compression caused a delayed increase in
thymidine incorporation (data not shown). Additional experiments demonstrated that this
delayed DNA synthetic induction could occur in response to a brief compression followed
by release of compression.
3.4.5 Effect of Transient Compression on DNA and Glycosaminoglycan Synthesis.
Smooth muscle cell-collagen gel cultures were exposed to a brief compression (5
min, 50% strain) followed by release and then were pulse-labeled with 3H-thymidine for 24
hours at 0, 24, 48, or 72 hours after compression. Transient compression led to a delayed
increase in 3H-thymidine incorporation (Figure 3.10); at 24 hr after compression,
incorporated counts were 800 + 290 cpm/gel (vs. 750 + 20 cpm/gel for control, p = NS);
at 48 hr, there were 3000 + 620 cpm/gel (vs. 990 + 100 cpm/gel for control, p < 0.005); at
72 hr, there were 340 + 90 cpm/gel (vs. 340 + 10 cpm/gel for control, p = NS); and at 96
hr, there were 310 + 140 cpm/gel (vs. 240 + 20 cpm/gel for control, p = NS). However,
transient compression led to a parallel decrease in 35S-sulfate incorporation (Figure 3.11);
at 24 hr after compression, incorporated counts were 520 + 40 cpm/gel (vs. 500 + 90
cpm/gel for control, p = NS); at 48 hr, counts were 400 + 50 cpm/gel (vs. 450 + 30
cpm/gel for control, p= NS), at 72 hr, counts were 350 + 30 cpm/gel (vs. 430 + 20 for
control, p < 0.005); at 96 hr, counts were 230 + 20 cpm/gel (vs. 350 + 20 for control, p <
0.001).
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Figure 3.10. Time course of 3H-thymidine incorporation by vascular smooth muscle cells in collagen gel
culture after a transient (5 min, 0.50 strain) compression and release of compression at time 0 () ,
relative to unloaded control (0). Data represent mean + sd for n=3.
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Figure 3.11. Time course of 35S-sulfate incorporation by vascular smooth muscle cells in collagen gel
culture after a transient (5 min, 0.50 strain). compression at time 0 (U), relative to unloaded control (0).
Data represent mean + sd for n = 4.
3.5 Discussion
Mechanical loading of vascular smooth muscle cells in a two-dimensional
monolayer configuration has been shown previously to control proliferation and matrix
synthesis. In this chapter, the effect of mechanical compression on smooth muscle cell
DNA and glycosaminoglycan synthesis was evaluated in a three-dimensional collagen
-
I
lattice. Sustained, static uniaxial and unconfined compression decreased both DNA and
glycosaminoglycan synthesis in a stress-dependent manner. Total radiolabel in the gel
decreased with the compressive stress, but the equilibrium intra-gel radiolabel
concentration did not decrease with stress, suggesting that incorporation was not limited
by radiolabel access. Decreased 3H-thymidine incorporation was reversed after release of
24 hr compression, and a brief transient compression caused a delayed increase in 3H-
thymidine incorporation but decreased 35S-sulfate incorporation.
Because biosynthesis was maximally inhibited by a low magnitude of stress (- 1
kPa) relative to typical mean intravascular pressure, it was hypothesized that decreased
DNA synthesis was coupled to the gel deformation rather than to the absolute applied
force. When the displacement rather than load was controlled, DNA synthesis decreased
relatively linearly with the imposed compressive gel strain. These observations suggest
that cells respond to their own deformation rather than to the absolute stress applied to the
bulk tissue. As discussed in Chapter 1, cellular deformation is a function not only of the
applied load, but also of the ensemble material compliances. Thus, vascular smooth
muscle cells in the very compliant gel matrix may be more responsive to a given applied
stress than the same cells would be in a stiffer matrix, such as in the blood vessel. This
model may also suggest that decreased vascular compliance associated with hypertension
is a compensatory mechanism to maintain smooth muscle cell strain.
Whether cells respond to their own deformation or to an applied bulk stress might
be directly tested experimentally by constituting gel cultures of varying mechanical
compliance (by altering the concentration of Vitrogen 100, for example), and comparing
their biological responses to both controlled-load and -displacement compression;
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however, such an experiment might be difficult to interpret given that the matrix
composition itself can regulate cellular function. Indeed, given the reduction in gel
volume under static compression, one mechanism for decreased biosynthesis may be
increased matrix concentration. For several additional reasons, the three-dimensional gel
culture is not ideal for performing experiments to dissect the specific role of cellular strain
in mechanical responses. These issues and related experiments are presented in Chapters 5
and 6.
For now, additional questions remain concerning the biological mechanisms
underlying the responses presented -in this chapter. For example, the extent to which cells
were injured by compression is unknown. Although total DNA content remained
constant, decreased biosynthesis during static compression might be consistent with
sublethal cell injury. In addition, the mechanism for increased DNA synthesis during
release of compression was not characterized, but could involve intracrine pathways,
autocrine/paracrine pathways, or a combination of both. The induction of DNA synthesis
was accompanied by a decrease in glycosaminoglycan synthesis, suggesting a specific
response rather than a generalized change in metabolic activity. In the next chapter, the
mechanism for DNA synthetic induction by transient compression is further characterized.
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Chapter
4
Characterization of DNA Synthetic Induction by Transient
Compression
4.1 Abstract
Although mechanical vascular injury leads to smooth muscle cell proliferation that
contributes to restenosis following balloon angioplasty, the role of the single transient
mechanical stimulation of smooth muscle cells in this process is unknown. In this chapter,
the DNA synthetic response to transient compression, described in Chapter 3, was further
characterized. Transient compression (5 min duration) of smooth muscle cell-collagen gel
cultures in defined serum-free conditions led to delayed increases in 3H-thymidine
incorporation. At 12-24 hours after compression, there was a 3.3 + 0.5 (p < 0.001 vs.
control) and 3.0 + 0.6 (p < 0.002 vs. control) fold increase for 60% and 80% strain,
respectively; at 24-36 hours after compression there was a 1.8 + 0.5 (p < 0.05 vs. control)
and 4.3 + 0.8 (p < 0.001 vs. control) fold increase. Additionally, serum-free media
conditioned by transiently compressed gel cultures induced DNA synthesis in control,
unstimulated smooth muscle cell cultures, suggesting the release of growth factors by
transient compression. Although neutralizing antibodies against platelet-derived growth
factor (PDGF) did not affect the mechanical induction of DNA synthesis, a neutralizing
monoclonal antibody against fibroblast growth factor-2 (FGF-2) decreased this induction
by '89% and completely blocked the increase in DNA synthesis caused by media
conditioned by transiently compressed gels. Media conditioned by transient compression
contained elevated levels of FGF-2 (17 + 5 pg/ml vs. 2 + 2 pg/ml for control, p < 0.005)
with no increase in lactate dehydrogenase activity, suggesting release of FGF-2 with
sublethal cellular injury. Thus, a single transient mechanical stimulus increases DNA
synthesis in human vascular smooth muscle cells, in part by autocrine or paracrine FGF-2
release.
4.2 Introduction
Although percutaneous transluminal coronary angioplasty is widely used in the
treatment of coronary atheroma, the success of this procedure is often limited by late
restenosis. Within months following angioplasty, 20% - 40% of patients develop
recurrent neointimal lesions consisting of abundant extracellular matrix and hyperplastic
vascular smooth muscle cells.' 48  A cascade of pathways involving vascular smooth
muscle cells, endothelial cells, platelets, and macrophages may mediate neointimal growth
through cytokines and growth factors.' 48 The vascular responses to the direct mechanical
strain of balloon angioplasty, as well as to acute local thrombosis, may be important early
events in this cascade.
Mechanical forces may influence biological responses through various signal
transduction mechanisms to alter structure and function at the cellular and molecular
level. 54' 82"49 Vascular smooth muscle cells in vivo undergo dynamic and static mechanical
strains from superimposed pulsatile and mean pressure loads of the cardiac cycle, and
these strains may be altered in pathological conditions such as hypertension. 71'74"132"150
Several in vitro studies have assessed potential biologic responses of vascular smooth
muscle cells to physiologically relevant mechanical conditions. For example, dynamic
mechanical strain can modulate cellular orientation, 69'  matrix synthesis,68, 73 and
proliferation7 'o72,151 of cultured vascular smooth muscle cells, and continuous static strain
increases proto-oncogene expression and phosphoinositide turnover."'
During balloon angioplasty, smooth muscle cells and other vascular cells are
exposed to a transient mechanical strain of relatively large magnitude, as the vessel is
dilated briefly and then allowed to relax. In vivo studies of balloon injury demonstrate
intimal smooth muscle cell hyperplasia caused both by migration from the media and
increased proliferation,43 ,152 and these processes may be mediated by platelet-derived
growth factor (PDGF) and fibroblast growth factor-2 (FGF-2). PDGF is both a mitogen
and a chemoattractant for vascular smooth muscle cells,42 which may be synthesized and
released by platelets, smooth muscle cells, and endothelial cells.153 In animal models,
vascular injury induces expression of mRNA for the PDGF-A chain and also the PDGF
receptor-a and -3 subunits in the neointima. ' s5"," Additionally, intimal thickening induced
by injury can be inhibited by a polyclonal antibody against PDGF. 156  Under some
conditions, PDGF can be mechanically induced in cultured vascular smooth muscle cells."
FGF-2, also known as basic fibroblast growth factor, may be essential for the early
smooth muscle cell proliferative response in injured rat arteries. Like PDGF, FGF-2 is
mitogenic and chemotactic for vascular smooth muscle cells in vitro and can be
synthesized by both vascular smooth muscle cells and endothelial cells. s57 s58 This growth
factor lacks a signal sequence for classical secretion,' 59 and may be released upon cell
injury. 160-'162 In rat arteries, injury-induced smooth muscle cell proliferation is significantly
greater with combined injury to endothelial and smooth muscle cells than with endothelial
denudation alone,'63 can be inhibited by a neutralizing antibody against FGF-2,'64 and does
not require circulating platelets.165 In addition, balloon injury leads to increased
expression of mRNA for both FGF-2 and its receptor by smooth muscle cells and
endothelial cells.'66
Although animal models of restenosis have revealed potential mechanisms of
smooth muscle cell proliferation, they have not readily dissected the specific role of the
transient mechanical strain on smooth muscle cell responses. This study was designed to
test the hypothesis that a single transient mechanical strain can induce DNA synthesis in
human vascular smooth muscle cells, potentially mediated by autocrine growth factors.
4.3 Materials and Methods
4.3.1 Cell Culture.
Human vascular smooth muscle cells were derived from, explants of discarded
portions of saphenous veins obtained during coronary bypass surgery performed at
Brigham and Women's Hospital. Monolayer smooth muscle cells were cultured in
Dulbecco's Modified Eagle Medium (DMEM) (Whittaker Bioproducts, Inc.) with 10%
fetal calf serum (FCS), at 370 C and 5% CO2. These conditions are selective for growth of
smooth muscle cells over endothelial cells.' 43 The explant and culture technique was
identical to the protocol used in previous studies of cultured vascular smooth muscle
cells. 39,14 4 ,145 Cells were cultured through passages 3 - 5 prior to transfer to a three-
dimensional collagen gel culture system for use in transient compression experiments.
Cell culture in hydrated collagen gels was performed with Vitrogen 100 collagen
(Celtrix Pharmaceutical) as previously described.' 46 Cells (2.5 - 3.0 x 105) were
suspended in 1.25 ml collagen (2.8 mg/ml) and cultured in standard 24-well (16 mm
diameter) culture plates (Costar Corporation). Gel cultures were maintained in DMEM
supplemented with 10% FCS and 0.07 mmol / L ascorbate-2-phosphate (Wako Pure
Chemical Industries) and received a change of culture medium every two days. The
contraction of collagen gel matrices by these cells may be resisted by local adhesions to
the culture plate wells; thus, to facilitate uniform, axisymmetric gel contraction, on day 5
the gel cultures were gently detached from the sides of the wells. Over the course of 10
days in culture, smooth muscle cell-gels contracted uniformly to disks with nearly identical
dimensions in a given experiment; the standard deviation of gel thickness, measured by
micrometer prior to compression, was less than 5% of the mean. Final contracted gel
diameter ranged from 4.5 - 7.0 mm, and thickness ranged from 1.0 - 2.5 mm in different
experiments.
4.3.2 Mechanical Compression.
Smooth muscle cell-gel cultures received a final media change on day 10 and were
subjected to a uniaxial, unconfined, transient compression consisting of a brief fixed-
displacement static compression, followed by release of compression. For serum-free
conditions, smooth muscle cell-gels were washed six times on day 9 with defined, serum-
free IT medium (equal volumes of DMEM and Ham's F-12 supplemented with 1 tiM
insulin and 5 pg/mi transferrin) at 370 C and further incubated for 24 hours in this medium
prior to the transient compression. The compression apparatus consisted of a base to hold
the culture plate and a rigid top compression plate (Figure 4.1). Compression platens and
spacer posts, machined from autoclavable polysulfone rod stock (Patriot Plastics &
Supply, Inc.) to a uniform length (19.05 mm), were affixed to this top plate and
concentrically aligned with culture plate wells. By lowering the top plate assembly, static
compression was applied to the gels by the compression platens at a desired strain
determined by the thickness' of Teflon disks positioned beneath the spacer posts within
vacant adjacent wells; this imposed strain ranged from 50 - 80% of the initial gel thickness
in all experiments. For most experiments, a moderate strain of 50-65% was used; the 80%
strain was used for evaluating the effect of higher amplitudes of initial strain. The duration
of transient compression ranged from 0.2 - 5.0 minutes; by 2 hours after removal of
compression, the gels were observed to reswell to a state of <10% strain. Parallel control
smooth muscle cell-gels were not compressed but were otherwise handled in identical
fashions.
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Figure 4.1 Diagram of apparatus used to apply transient mechanical compression to three dimensional
vascular smooth muscle cell cultures (SMC-Gel). A Compression Plate was lowered on to the gel
cultures, and strain was limited by Teflon disks. After a brief period (usually 5 min), the Compression
Plate was removed.
4.3.3 3H-Thymidine Incorporation.
Following compression, culture media were supplemented with methyl-[3H]-
thymidine, 6.7 mCi / mmol, (Dupont-NEN) to measure DNA synthesis. To assess time
course, designated smooth muscle cell-gels were radiolabeled during consecutive 12-hour
periods; additional control gels were radiolabeled during the 12 hours preceding the
transient compression and served as an initial baseline. Following radiolabeling, smooth
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muscle cell-gel matrices were solubilized overnight in 4 M urea, 0.5% sodium dodecyl
sulfate, and precipitated with 10% trichloroacetic acid at 40 C. Precipitates were vacuum-
collected on 0.45 gm filters (Millipore Corp.) and washed with 10% trichloroacetic acid at
40 C. Filters were air-dried, mixed with Ecolume (ICN Biomedicals) scintillation cocktail,
and counted with a scintillation counter (Pharmacia LKB Nuclear). To assess nonspecific
radiolabeling of the gel matrices, parallel smooth muscle cell-gel cultures in some
experiments were subjected to three cycles of freezing at -80 ° C and thawing at 370 C
prior to radiolabeling. The nonspecific counts were generally less than 5% of those in the
live smooth muscle cell-gel cultures.
4.3.4 Conditioned-Media Experiments.
To test the hypothesis that transient compression of the smooth muscle cell-gel
cultures triggers release of mitogens from the cells, conditioned-media experiments were
performed. Smooth muscle cell-gel cultures were either compressed for 5 minutes (60%
strain) or were not compressed, and then further incubated for 24 hours. Culture media
were then exchanged between the two groups and supplemented with 4 pCi/ml methyl-
[3H]-thymidine for 24 hours of radiolabeling. Uncompressed control gels were incubated
for 24 hours, and the media were removed and immediately returned to the identical wells
prior to radiolabeling.
4.3.5 Antibody Neutralization Experiments.
Smooth muscle cell-gel cultures, made quiescent under defined serum-free
conditions as described above, were subjected to transient compression (60% strain, 5
min). In separate experiments, neutralizing polyclonal rabbit antibodies against either
human PDGF-A (10 pg/ml) or PDGF-B (5 jpg/ml) (Genzyme Corporation) chain were
added to designated culture media immediately following release of compression, and the
gel cultures were further incubated for either 12 or 24 hours. Media were then
supplemented with 4 pCi methyl-[3H]-thymidine for 12 hours of radiolabeling. For
positive controls, exogenous recombinant human PDGF-AA (2 ng/ml) or PDGF-BB (4
ng/ml) (Genzyme Corporation) was added to the culture media of control (unstimulated)
smooth muscle cell-gels either in the presence or absence of the appropriate neutralizing
anti-PDGF antibody.
In similar experiments, we assessed the ability of a neutralizing monoclonal
antibody against human FGF-2 (0.1, 1.0, or 10 gg/ml, Upstate Biotechnology Inc.) to
inhibit the induction of 3H-thymidine incorporation by transient compression (65% strain,
5 minutes). A non-immune mouse IgG antibody (10 jLg/ml, Sigma) was added to parallel
cultures to assess the specificity of the anti-FGF-2 antibody. As a positive control,
exogenous human recombinant FGF-2 (10 ng/ml, Upstate Biotechnology Inc.) was added
to the culture media of control smooth muscle cell-gels either in the presence or absence
of the anti-FGF-2 antibody.
4.3.6 Measurement of FGF-2 and Lactate Dehydrogenase Activity.
Serum-free media conditioned for 12 hours by transiently compressed and control
gels were harvested and assayed for FGF-2 with a quantitative enzyme immunoassay
(R&D Systems, Quantikine Human FGF basic Immunoassay). To assess cell injury,
lactate dehydrogenase (LDH) activity in the media was measured with a quantitative,
colorimetric assay (Sigma). The lower limit sensitivity of this assay was 40 units/ml.
Parallel media, conditioned by gel cultures subjected to three cycles of freeze-thaw, were
used as positive controls.
4.3.7 Measurement of Total DNA Content
To further assess cell injury, total DNA in smooth muscle cell-gel cultures was
measured at 12 hours following transient compression (65%/q) and compared with that in
uncompressed gel cultures. Smooth muscle cell-gel cultures were frozen, lyophilized, and
digested in 1 ml/gel papain (Sigma, 125 mg/ml) for 24 hours at 600 C. Hoechst 33258 dye
solution was added to digest aliquots in an acrylic cuvet, and DNA content was measured
fluorometrically, using calf thymus DNA as a standard. 147
4.3.8 Measurement of FGF-2 mRNA.
Total cellular RNA in smooth muscle cell-gel cultures was isolated by guanidine
isothiocyanate extraction at 0, 0.5, 1, 2, 3, and 12 hours following compression; RNA
extracted from smooth muscle cells treated for 30 min. with either IL-1 or 10% fetal calf
serum was used as positive controls. Total RNA (7.5 gg) of each sample was
electrophoresed in the presence of ethidium bromide on 1.4% agarose gels containing
formaldehyde and transferred to nylon hybridization membranes. Blots were
photographed under UV illumination to verify evenness of loading and transfer, UV
immobilized, and then hybridized to a 1.2 kb cDNA probe (gift of Prof. M. Klagsbrun,
Children's Hospital, Boston) for FGF-2 which was labeled with 32P-dCTP using the
random primers method. Blots were washed and autoradiographed with x-ray film for 3
days at -800 C.
4.3.9 Statistics.
All data are presented as mean + one standard deviation for n = 3 or 4
measurements. For comparison between specific groups of continuous variables, the two-
sample Student's t test was used. A p value < 0.05 was considered statistically significant.
The findings reported below are representative of results of at least two independent
experiments.
4.4 Results
4.4.1 DNA Synthesis Following Transient Strain.
In serum-supplemented conditions, transient compression (5 min) led to an
increase in 3H-thymidine incorporation by vascular smooth muscle cells in collagen gels,
following an initial period of decreased incorporation (Figure 4.2). From 12 to 24 hours
after release of compression of 60% or 80% strain, there were no differences in 3H-
thymidine incorporation relative to control; from 24 to 36 hours, there was a 1.6 + 0.4 (p
< 0.05 vs. control) and a 2.4 + 0.6 (p < 0.005 vs. control) fold increase in 3H-thymidine
incorporation for 60% and 80% strain, respectively.
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Figure 4.2. Increase in 3H-thymidine incorporation by human vascular smooth muscle cells following a 5
min compression at time 0 in the presence of 10% fetal calf serum at strains of 60% (0) or 80% (M).
Control 12-hour incorporated counts were 710 + 220, 560 + 210, 1290 + 207, and 930 + 140 cpm, at 0,
12, 24, and 36 hours following compression. n = 3 or 4 for each measurement, error bars denote one
standard deviation.
Exogenous serum-associated growth factors were not required for the mechanical
induction of DNA synthesis. In defined serum-free medium, transient compression of gel
cultures again led to a delayed increase in 3H-thymidine incorporation (Figure 4.3). From
i
12 to 24 hours after release of compression, there was a 3.3 + 0.5 (p < 0.001 vs. control)
and 3.0 + 0.6 (p < 0.002 vs. control) fold increase in 3H-thymidine incorporation for 60%
or 80% strain, respectively; from 24 to 36 hours, there was a 1.8 + 0.5 (p < 0.05 vs.
control) and a 4.3 + 0.8 (p < 0.001 vs. control) fold increase in 3H-thymidine
incorporation for 60% and 80% strain, respectively. Cumulative incorporated counts
during the 36-hour period following compression were 1670 + 120, 2730 + 440, and 3960
+ 470 cpm, for 0%, 60%, and 80% compressions, respectively (p < 0.001 by analysis of
variance). Maximum inductions of 3H-thymidine incorporation by strains of 60-65% in
different experiments ranged from 1.6 to 3.0-fold in the presence of serum (five
experiments), and from 1.8 to 10-fold in the absence of serum (seven experiments).
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Figure 4.3. Increase in 3H-thymidine incorporation by human vascular smooth muscle cells following a 5
min compression at time 0 in defined serum-free conditions at strains of 60% (0) or 80% (0). Control
12-hour incorporated counts were 730 + 200, 350 + 70, and 590 + 120 cpm, at 12, 24, and 36 hours
following compression. n = 4 for each measurement, error bars denote one standard deviation.
To minimize potential effects of exogenous mitogens and other serum constituents,
further characterization of this induction of 3H-thymidine incorporation was performed
under serum-free conditions. Defined serum-free media conditioned for 12 hours by
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transiently compressed gels increased 3H-thymidine incorporation in target control
(unstimulated) gels by 2.5 + 0.5 fold over control media (p < 0.005). Conversely,
transiently compressed gels whose media were replaced with control media demonstrated
no induction in DNA synthesis. These data suggested the release of autocrine growth
factor(s) by transient compression of the smooth muscle cell-gels.
4.4.2 Autocrine Growth Factor Studies.
Antibody neutralization experiments were performed under serum-free conditions
to study the possible role of specific endogenous growth factors. Neutralizing antibodies
against either PDGF-A (Figure 4.4A) or PDGF-B (Figure 4.4B) chain did not inhibit
induction of 3H-thymidine incorporation by transient compression. In parallel control
experiments, neutralizing antibodies to PDGF were able to block the induction of 3H-
thymidine incorporation by the appropriate exogenous PDGF homodimers. However, a
monoclonal anti-FGF-2 neutralizing antibody inhibited strain-induced 3H-thymidine
incorporation in a dose-dependent manner, achieving 89% inhibition (p < 0.01 vs.
compressed) at 10 pg/ml (Figure 4.5), while the non-immune IgG antibody at that
concentration had no effect. In control experiments, the monoclonal anti-FGF-2 antibody
also completely blocked the induction of 3H-thymidine incorporation by exogenous FGF-
2. Although nearly complete inhibition of compression-induced 3H-thymidine
incorporation was achieved in this experiment, inhibition by the monoclonal anti-FGF-2
antibody (10 gg/ml) ranged from 65-89% in four independent experiments using a strain
of 60 - 65%. Additionally, compression-conditioned media significantly induced 3H-
thymidine incorporation in target gel cultures by 1.7 + 0.2 fold over control-conditioned
media (p < 0.001), and this induction was completely blocked by the monoclonal anti-
FGF-2 antibody (Figure 4.6).
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Figure 4.4. 3H-thymidine incorporation by human vascular smooth muscle cells 12-24 hr following a 5
min, 60% compression (Comp) in serum-free conditions. Control cell-gels received no stimulation. (A)
Addition of a neutralizing polyclonal antibody to PDGF-A immediately following compression
(Comp+anti-AA) did not inhibit the effect of transient compression (Comp) (p = ns). Addition of PDGF-
AA in the absence of compression led to an increase in 3H-thymidine incorporation (PDGF-AA) that was
inhibited by the polyclonal antibody (AA+anti-AA). (B) Addition of a neutralizing polyclonal antibody
to PDGF-B immediately following compression (Comp+anti-BB) did not inhibit the effect of transient
compression (Comp) (p = ns). Addition of PDGF-BB in the absence of compression led to an increase in
3H-thymidine incorporation (PDGF-BB) that was inhibited by the polyclonal antibody (BB+anti-BB). n
= 3 or 4 for each measurement, error bars denote one standard deviation.
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Figure 4.5. 3H-thymidine incorporation by human vascular smooth muscle cells 12-24 hr following a 5
min, 65% compression (Comp) in serum-free conditions. Control cell-gels received no stimulation. The
effect of transient compression was inhibited by a neutralizing monoclonal antibody to FGF-2 (10 .g/ml,
p < 0.005) added immediately following compression (Comp+antiF10), but was unaffected by a mouse
non-immune IgG (10 jgg/ml) (Comp+IgG10). Nonsignificant inhibitory effects of lower concentrations of
antibody to FGF-2 are shown (comp+antiFl, 1 •nml; comp+antiF.1, 0.1 Lg/ml). Addition of FGF-2 in
the absence of compression led to an increase in H-thymidine incorporation (FGF-2) that was inhibited
by the monoclonal antibody (FGF-2+anti-F10). n = 3 or 4 for each measurement, error bars denote one
standard deviation.
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Figure 4.6. Ability of conditioned media from transiently compressed vascular smooth muscle cell-gel
cultures to increase 3H-thymidine incorporation by unstimulated gel cultures. Media harvested 12 hr
following a 5 min, 60% compression (Comp) or no compression (Control) were transferred to
unstimulated gel cultures, and 'H-thymidine incorporation was measured from 12-36 hr later. The
stimulatory effect of the compression-conditioned media was reversed by a neutralizing monoclonal
antibody to FGF-2 (Comp+anti-FGF-2) (p < 0.001 vs. Comp). n = 4 for each measurement, error bars
denote one standard deviation.
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To assess the release of FGF-2 in response to transient compression, culture media
were analyzed by a quantitative immunoassay. Increased levels of FGF-2 were found in
serum-free media 12 hours after transient compression (Table 4.1). Analysis of media
following freeze-thawing of the gel cultures demonstrated that the released FGF-2
represented only a small component (< 3%) of total available FGF-2. There was no
significant increase in LDH release following the transient compression stimulus. In
another experiment, DNA content in compressed gels (3.71 + 0.08 ~ig/gel) was no
different from that in control gels (3.63 + 0.07 gtg/gel) at 12 hours after mechanical
stimulation, suggesting that the FGF-2 release occurs without widespread cell death. In
addition, Northern analysis demonstrated no differences in FGF-2 mRNA levels at 0, 0.5,
1, 2, 3, and 12 hours after compression, and these levels were low compared to those in
cells stimulated with IL-1 or serum (data not shown).
Control Compressed Freeze-Thaw
FGF-2 (pg/ml) 2+2 17 + 5 * 725 + 47 *
LDH (units/ml) < assay < assay 1040 + 300 *
Table 4.1 FGF-2 and LDH in culture media 12 hr following 5 min, 60% compression of the three-
dimensional smooth muscle cell gel cultures in serum-free condition. Parallel gel cultures were subjected
to three cycles of freezing and thawing without compression. The lower limit sensitivity of the LDH assay
was 40 units/ml. * p < 0.005 vs. control, n = 4.
4.5 Discussion
A cascade model for restenosis is emerging in which mechanical strain, as well as
acute local thrombosis, may trigger the early expression of cytokines and growth factors
by smooth muscle cells and macrophages. 148 These mediators stimulate multiple cell types
in paracrine and autocrine fashions to regulate their own expression or induce one another.
Amplification feedback loops and redundant pathways may be ushered in, circumventing
therapeutic modalities intended to block a specific growth factor or cytokine. Thus,
understanding the initial cellular responses to mechanical strain may be important for
identifying rational therapeutic targets early in the cascade.
The previous chapter demonstrated that smooth muscle cells in a collagen matrix
respond biologically to both static and transient compression. In this chapter we further
characterized the induction of DNA synthesis in response to transient compression of the
matrix. Transient compression of human vascular smooth muscle cell-collagen gel
cultures increased DNA synthesis in a delayed, strain-dependent fashion, without
exogenous serum-associated mitogens. Conditioned-media experiments demonstrated
that DNA synthetic induction was not solely mediated by an intracellular mechanism.
Although antibodies against PDGF-A or PDGF-B chain had no effect on the DNA
synthetic response, a monoclonal antibody against FGF-2 inhibited the mechanical
induction of DNA synthesis. In addition, increased levels of FGF-2 in the culture media
after compression were measured by a quantitative immunoassay. Taken together, these
data strongly suggest that transient mechanical strain of in vitro vascular smooth muscle
cells stimulates DNA synthesis, in part by autocrine release of FGF-2.
In a series of experimental restenosis studies, Reidy and colleagues made the
important observation that early smooth muscle cell proliferation in response to vascular
injury is probably mediated not by PDGF from platelets, but instead by FGF-2 released
from injured medial smooth muscle cells.43 However, given the potential dual roles of
FGF-2 and PDGF in promoting migration and proliferation of smooth muscle cells, 42,167-17 0
and the multiple sources of these factors,'53'157, •58 in vivo experiments have not directly
assessed the ability of isolated vascular smooth muscle cells to proliferate in direct
response to a transient mechanical strain. The present study offers direct evidence for
autocrine FGF-2 in mediating the induction of DNA synthesis by transient mechanical
stimulation of these cells.
Following transient compression, FGF-2 was released presumably from pre-
existing stores without increased FGF-2 gene expression; while FGF-2 mRNA levels in the
compressed gel cultures did not change during the 12 hour period following compression,
FGF-2 levels in conditioned media increased by several fold. FGF-2 lacks a leader
sequence for the classical secretory pathway and is believed to be stored in the cytoplasm
or nucleus and released upon disruption of the cell membrane or by a novel
uncharacterized secretory mechanism. '61 ' ,17 ' 72 In our experimental model, FGF-2 release
was not accompanied by lethal smooth muscle cell injury, as assessed by LDH activity and
total gel DNA content; however, these parameters may be insensitive to minor cell injury.
Such injury might account for the observed initial period of decreased DNA synthesis
following compression. Although the amount of FGF-2 released was less than 3% of the
total presynthesized pool, it should be noted that measurements of FGF-2 in the media
may underestimate local concentrations, since FGF-2 is selectively bound to heparan
sulfate proteoglycans and sequestered from the high-affinity cell surface receptors.173
Thus, we do not know whether FGF-2 is being released from smooth muscle cells
undergoing minor focal injury, from extracellular matrix sites disrupted by the mechanical
strain, or from both; further study with this system may elucidate mechanisms of strain-
induced FGF-2 release.
Although autocrine FGF-2 may be critical to the mechanical induction of DNA
synthesis, additional mechanisms are likely. First, inhibition of strain-induced DNA
synthesis by the neutralizing anti-FGF-2 monoclonal antibody was incomplete, suggesting
the existence of FGF-2-independent autocrine and/or intracellular mechanisms. Second,
while conditioned-media treatment led to increased DNA synthesis which could be
blocked by the neutralizing antibody, the concentration of FGF-2 measured in this
conditioned media was lower than exogenous FGF-2 concentrations (> 1 ng/ml) needed to
induce DNA synthesis in these serum-deprived gel cultures. Thus, mechanically induced
DNA synthesis may depend on the release of additional factors. Under certain conditions,
the mitogenic effects of FGF-2 on vascular smooth muscle cells can be potentiated by
other growth factors such as PDGF,174 and an autocrine PDGF-dependent growth
response to continuous cyclic strain has been described in cultured neonatal rat vascular
smooth muscle cells.71 However, a similar role for PDGF in our transient strain system
was not observed, reflecting possible dependence of cellular responses on the nature of the
mechanical strain (transient vs. dynamic) or on culture configuration (three-dimensional
vs. monolayer).
The relationship between gel deformation and the associated cellular strains may
lend insight to the mechanotransduction mechanism(s). Biosynthesis in the experiments of
this and the previous chapter appear to be regulated by the imposed gel strain, suggesting
that cellular deformation determines the magnitude of these responses. Although the
three-dimensional culture used in this thesis has the potential advantage of providing a
mechanical environment for the cell that is more similar to the in vivo situation, the cellular
strain within the compressed gel may be spatially variable and difficult to assess. In the
next chapter, the relationship between cellular and culture substrate strain is discussed and
a device is developed to impose homogeneous and uniform strain to cells grown in a
monolayer configuration.
The DNA synthetic response we have observed may have implications not only for
restenosis, but for development and progression of atherosclerosis, in general. Although
atherosclerosis is multifactorial, 175 vascular insult from mechanical and/or biochemical
sources is believed to be a major predisposing factor.20 These data indicate that vascular
smooth muscle cells may be sensitive to brief, sublethal variations in mechanical strain, and
further emphasize the potential influence of mechanical forces on vascular cell biology.
Additional study of the early smooth muscle cell responses to mechanical stimuli may
reveal promising therapeutic targets for vascular diseases.
Chapter
5
Development of Membrane Strain Device: Preliminary
Assessment of FGF-2 and IL-l a Release by Cellular Strain
5.1 Abstract
The previous chapters characterized the capacity of mechanical loading to control
cellular function within a three-dimensional matrix. Static compression of smooth muscle
cell-collagen gel cultures decreased DNA and glycosaminoglycan synthesis, while transient
compression led to a delayed induction of DNA synthesis by autocrine FGF-2 release. An
advantage to using the three-dimensional culture over a two-dimensional configuration is
that it may more closely simulate certain cell-matrix interactions. A disadvantage to the
gel compression experiment, however, is that cellular strains are potentially variable and
cannot generally be interpolated from the imposed gel strain. To characterize the specific
dependence of cell function on cellular strain, a prototype device previously used to apply
homogeneous and equi-biaxial strains to cells in monolayer was re-designed and
constructed. Strains were found to be homogeneous and uniformly biaxial under 1) static
static deformation for the membrane, the matrix-coated membrane, and cells adhered to
the matrix-coated membrane; and 2) oscillatory deformation for the membrane alone. In
preliminary experiments, a single, rapid strain impulse (15% to 55% amplitude) induced
the release of FGF-2 in a strain amplitude-dependent fashion. In addition, human
keratinocytes released IL-la after an impulsive strain (40%, < 1 sec duration), but not
after sustained oscillatory strain (1 Hz, 15%, 1 hr duration). Thus, certain cellular
functions may be tightly regulated by cellular strain.
5.2 Introduction
The experiments of the two previous chapters demonstrate the metabolic
responsiveness of a three-dimensional smooth muscle cell-matrix culture to mechanical
loading. Static, uniaxial, unconfined compression of cylindrical collagen gel cultures
decreased DNA and glycosaminoglycan synthesis by human vascular smooth muscle cells,
but a transient compression induced DNA synthesis by autocrine release of FGF-2. The
imposed matrix strain, rather than the applied stress, appeared to regulate the response;
biosynthesis decreased linearly with gel compression over a wide range of strain (0-80%)
but due to the compliance of the gel, the range of associated stresses (0 - 1 kPa) was
extremely narrow compared to the range typically experienced by the normal vessel wall.
These observations suggest that a cell responds specifically to its own deformation, and
thus its ability to sense a globally applied stress depends largely on the stiffness of its
surrounding extracellular matrix. This is not surprising since it is difficult to imagine how
a cell embedded in a matrix of hypothetically infinite stiffness would sense a finite external
stress at all. Thus, while signal transduction mechanisms that mediate cellular responses to
mechanical loading may be diverse, cellular strain could be a unifying early regulatory
parameter.
For several reasons, gel compression may not be the ideal method for assessing the
role of cellular strain in the regulation of cellular function. First, compression of the gel
culture may exert functional control not only through cellular deformation but also
through changes in matrix concentration, particularly for high strains (See Chapter 3).
Thus, it may be difficult to dissect the effect of cellular strain from that of modulating the
matrix environment. In addition, cellular strains cannot be precisely interpolated from the
imposed matrix strain. Although cellular deformation under uniaxial gel compression
would be expected to increase generally with the imposed matrix strain, individual cell
strains may be variable.
Figure 5.1 Uniaxial unconfined compression of cylindrical gel. Macroscopic strain profile is complicated
by friction at the top and bottom surfaces of the gel, but these edge effects could be minimized by confined
compression.
At the macroscopic level, material isotropy and homogeneity, as well as the
axisymmetric loading, suggest that the strain profile may be predicted (Figure 5.1).
However, this analysis would be limited by structural heterogeneity at the microscopic
level. In the vicinity of a given cell, the gel culture is a heterogeneous, anisotropic
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network of cell and matrix elements forming a structure similar to an engineering truss.
As is the case for truss elements, the strain in a given cell may vary from that of
neighboring cells, depending on its own orientation, and the orientation and elastic moduli
of its neighboring cell and matrix elements. The strains in the individual elastic elements
of this simple mechanical model (Figure 5.2) depend on the relative arrangements and
stiffnesses of those elements. Similarly, in the gel culture, differing orientations of cells and
matrix fibrils may lead to a spectrum of normal and shear cellular strains.
Figure 5.2 One-dimensional lumped-parameter mechanical model of cells (thin springs, k) and matrix
elements (thick springs, K) bearing compressive force embedded in series and parallel orientations.
Although overall gel strain is constrained by the platen displacement, the strains of the individual internal
components may be spatially variable due to random density and orientation of these elements. In reality,
both tension and compression-bearing elements resist the compression of the gel.
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Another limitation of the gel culture compression configuration is the inability to
apply oscillatory matrix strain at a moderate amplitude (e.g. 5%) and frequency (e.g. 1
Hz) such as that found in the arterial wall in vivo. The response of gel thickness following
release of compression of 50% magnitude has a time constant on the order of an hour
(Figure 5.3). Cyclic compression at 1 Hz, 10% amplitude would require forced oscillation
of the upper and lower gel boundaries, in both compression and tension, to entrain the gel
deformation to the desired frequency. Continuous contact between the platen and gel
would be difficult to maintain or verify throughout the loading period.
Figure 5.3 Viscoelastic response of gel culture after brief transient compression and release. Thickness
(T) returns to 90 % of its initial value after t - 1 hr.
A fourth limitation of the gel culture is the relative inability to detect cell injury. In
the transient compression-induced release of FGF-2 (Chapter 4), cell injury was not
detected by measurement of lactate dehydrogenase. More sensitive markers for injury rely
on cell visualization. Because the smooth muscle cell-collagen gel cultures are optically
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opaque at the time of compression, visualization of cells is restricted to those at the
surface of the gel.
Thus, the three-dimensional collagen gel culture that was useful for assessing
smooth muscle cell contraction and reorganization of matrix (Chapter 2) and metabolic
responsiveness to general mechanical loading (Chapter 3 and 4), presents several
limitations to characterizing the role of cellular strain. Although a suitable form of
mechanical loading could be developed for the three-dimensional matrix, the application
of strain to cells on a matrix-coated elastic membrane may offer several advantages. First,
the effect of cellular strain may be more effectively isolated from a matrix concentration
effect. Second, the strain profile in a thin membrane, under certain mechanical conditions,
can be theoretically modeled and experimentally verified. Third, because the extracellular
matrix coating is typically much thinner than either the cell layer or membrane, the
compliance of the matrix can be neglected in the assessment of cellular strain; given that
the cell-matrix and matrix-membrane interfaces remain rigidly intact, the cell focal
adhesions are constrained to move with the membrane. In addition, because the
membrane is much stiffer than the cells in parallel, the overall deformation is dominated by
the membrane (Figures 5.4 and 5.5), and the ability to perform oscillatory deformation
would be limited only by the membrane's material properties. Finally, cell
injury/morphology can be assessed microscopically if the membrane is optically
transparent.
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Figure 5.4 One-dimensional lumped-parameter mechanical model of cells (thin springs, k) and
membrane (thick springs, K) under tensile force T. Assuming cells are rigidly constrained to the
membrane through a thin matrix coating, the deformation of the ensemble is dominated by the membrane
because it is much stiffer than the cell layer.
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Figure 5.5 Schematic diagram of cellular deformation under tensile deformation of membrane (dotted
boundary). Focal adhesions (x) move with membrane displacement, so that average cell strain is
determined by membrane strain.
In this chapter a prototype device, used previously to impose homogeneous and
uniform biaxial strain to cultured cells, was re-designed and constructed. Strains were
experimentally verified to be homogeneous and biaxially uniform under 1) static
deformation in the membrane, matrix-coated membrane, and cells adhered to the matrix-
coated membrane; and 2) oscillatory deformation in the membrane. With this device, the
cellular release of FGF-2 and interleukin-la (IL-la) in response to cellular strain was
assessed in preliminary experiments. Like FGF-2, IL- is an ubiquitous cytokine which is
synthesized by a number of cells, including vascular smooth muscle cells,36,176 and exerts
numerous effects on various target cells. 177 The mechanism of IL-1 secretion is
incompletely understood; however, structural similarities between FGF-2 and IL-1 suggest
that these molecules share a common release mechanism: both are -17 kDa, have similar
three-dimensional structure by crystallography, 178 and lack a hydrophobic secretory leader
sequence.'17  We found that FGF-2 was released from human vascular smooth muscle
cells in response to either continuous cyclic strain of moderate frequency (1 Hz) and
magnitude (15%) or a single strain impulse. Conversely, IL-lac was rapidly released from
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human keratinocytes after a single strain impulse, but was not released by continuous
cyclic strain of moderate frequency and magnitude. The preliminary data suggest that
FGF-2 and IL-1 molecules 'can be liberated by cellular deformation, but that release is
dependent on certain characteristics of the imposed strain.
5.3 Materials and Methods
5.3.1 Prototype Device Modifications.
The prototype device designed by Prof. Martha Gray 2 has been used previously to
impose homogenous and uniform biaxial strain to cultured cells (Figure 5.6). Cells are
cultured on a thin circular, matrix-coated elastic membrane which is deformed from below
by a slightly smaller circular platen. The platen assembly moves vertically in a sinusoidal
fashion as its center shaft rides on a rotating cam shaft driven by a feedback-controlled
gear motor; at the lowest position on the cam, the membranes are in slight contact with
the platens but remain undeformed. The following modifications to the prototype design
were made to simplify operation and improve performance.
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Figure 5.6 Side view of the prototype device to impose homogeneous and equi-biaxial strain to cells
growth on a circular membrane.
Dishes and cassette. Access to dishes in the prototype device required the
dismounting and disassembly of a cassette (Figure 5.6). The cassette and dish designs
were modified so that each of four dishes was independently accessible (Figure 5.7). The
dish sits in a bottomless well of the cassette, and a locking collar sits on a ledge near the
base of the dish. The collar is rotated to engage three screws in the cassette which are
tightened to secure the dish. With this design, dishes can be loaded or removed in less than
10 seconds. The dish height was also increased to simplify manipulation.
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Figure 5.7 Side view of current device illustrating modifications made to simplify operation and improve
performance.
Platen assembly. Due to its material (Teflon) compliance and number of kinematic
degrees of freedom, the prototype platen assembly potentially contributed to variability in
membrane strain (Figure 5.6). The current platen assembly consists of four aluminum or
Delrin platens secured to a single aluminum platform (Figure 5.7). The platform thickness
(0.50") was selected to minimize bending during the loading cycle. The platform was
secured directly to a single drive shaft, and two lateral guide shafts each made of stainless
steel. These shafts were guided through an aluminum support beam by glass-filled Teflon
bearings (BOStonE F-i, Boston Gear) with a clearance of 0.001". With these
modifications, the weight of the platen assembly is sufficient to overcome friction in the
bearings and spring assistance is not required. The current device provides noticeably
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smoother vertical translation with less rotation and horizontal translation than achieved
with the prototype.
Cam and motor shaft. With the prototype device, cam changes required turning
the entire device on its side and removing a pillow block to release the cam shaft (Figure
5.6). The setscrews securing the cam to the shaft could then be loosened and the cam
released. Over time, the setscrew threads in the cam were observed to degrade. To
simplify cam changes, the shaft was lengthened to rotate in a bearing within the side wall
of the device, thereby eliminating the need for the pillow block (Figure 5.7). The cam was
rotationally constrained to the shaft with a key, and horizontal displacement of the cam
was constrained by two stainless steel collars. The cam could thus be removed by
loosening the cam shaft from the motor shaft, sliding the former off the latter, loosening
the inside collar, and sliding the cam off the end of the shaft. Cams were designed to
produce platen displacement amplitudes of 3.1, 5.4, 7.3, 9.4, and 17 mm and can be
changed in less than 30 seconds.
Motor, controller, and power supply- The previous motor was a 24 volt direct
current motor requiring separate transformer power supply and controller units connected
through extensive wiring. This motor was replaced with a 120V alternating current motor
(Bodine Electric Company) with a combined power supply and speed feedback-controller
connected by a single umbilical. The motor speed can be varied within a continuous
frequency range of 0 to 1 Hz.
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5.3.2 Cell Culture on Matrix-Coated Membranes.
Human vascular smooth muscle cells were derived from explants of discarded
portions of saphenous veins obtained during coronary bypass surgery performed at
Brigham and Women's Hospital. Smooth muscle cells were cultured in DMEM with 10%
FCS at 370C and 5% CO2. These conditions are selective for growth of smooth muscle
cells over endothelial cells.143 The explant and culture methods were identical to those
used in previous studies of cultured vascular smooth muscle cells.144,145  Cells were
cultured through passages 3 through 5 before transfer to membrane dishes for use in
mechanical strain experiments. Human keratinocytes and dermal fibroblasts were provided
by Prof. Thomas Kupper and maintained as previously described. Iso
Silicone elastomeric sheeting, Silastic, (0.005" thick, gloss/gloss, Specialty
Manufacturing) was prepared for cell culture by coating with either human plasma
fibronectin (Sigma) or Vitrogen 100 collagen (Celtrix Pharmaceutical). A silicone
membrane pre-treated with a surface coating of type I collagen (0.020", thickness Flexcell
Corp) was also tested. Cells were plated at a density of 5 - 15 x 103/cm 2 in DMEM
supplemented with 10% fetal calf serum and were trypsinized at various times to assess
proliferation.
5.3.3 Compatibility of Lubricant
A well-lubricated interface between platen and membrane is critical for achieving a
uniform strain profile in this configuration (see next section). Prior to their mechanical
evaluation, lubricants were tested for their ability to diffuse across the membrane and
affect cellular function. Several lubricants were obtained, including the partially
hydrogenated oil, Crisco, which had been previously used with the prototype device,2 and
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Braycote 804 (Castrol), a grease designed to be impermeant to silicone and chemically and
biologically inert. Cells were cultured on the matrix-coated membrane, the underside of
which was coated with lubricant.
5.3.4 Displacement of Platen (oscillatory, impulse, or step)
For many experiments oscillatory platen displacement was performed with the
motor set at a desired frequency. In some experiments it was desired to apply a rapid and
large magnitude displacement which exceeded the capabilities of the motor. A single
impulse or step of strain was applied by manually raising the platen assembly to a
displacement constrained by a rigid spacer inserted between the platen assembly platform
and the cassette. For an impulse, the platen was raised, held briefly, and then released.
Durations for the three stages of impulses performed by the author were assessed by video
analysis (Table 5.1); the total duration of the impulse for all displacements was < 1 sec.
For a step, the platen was raised and maintained at the desired displacement with another
spacer inserted between the assembly platform and the underlying support beam.
Platen displacement (mm) Raise (msec) Hold (msec) Lower (msec)
9.4 66 + 9.7 642 + 27 62 + 6
13.5 92 +10 600 + 53 78 + 6
19.3 130 + 11 570 + 15 86 +10
25.4 140 +19 560 + 46 100 + 6
Table 5.1 Duration of three impulse stages for various platen displacements performed manually. Data
represent mean + sd for n = 10 measurements.
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5.3.5 Estimation of Strain Distribution
The strain distribution within a circular membrane, deformed by the displacement
of a concentric circular platen, can be predicted geometrically from the relative dimensions
of the platen and dish, assuming a frictionless membrane-platen interface. Axisymmetric
deformation yields a condition of two-dimensional hydrostatic stress within the membrane:
ar = 00 (5.1)
ro, = 0. (5.2)
For a homogeneous, isotropic, linear elastic material,
1 1
er = (r - - eo) (5.3)E v
1 1
eeo= (o -- ar) (5.4)E V
where E = Young's Modulus and v = Poisson's Ratio.
Combining these equations, yields
er = eo  (5.5)
The strain component e, may be derived geometrically. For a platen of diameter r
and a membrane of diameter R, the membrane elongation in the radial direction (Figure
5.8) is
r-R+( - r)+-r x + 2
=(5.6)R
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where x is the vertical platen displacement. Assuming a frictionless membrane-
platen interface,
e, =A (5.7)
membrane
)L
r ,IIE
R
Figure 5.8 Side view of deformation of circular membrane by circular platen displacement, x.
Using equation 5.6, strain amplitudes for various platen displacements with r =
31.1 mm and R = 36.5 mm were predicted (Figure 5.9).
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Figure 5.9 Predicted membrane strain amplitudes for various cam displacement amplitudes.
5.3.6 Dependence of Strain Magnitude on Oscillatory Platen Displacement
Although the circular cams displace the platen assembly in a sinusoidally time
varying manner, the difference between platen and membrane radii (R - r) contributes to a
skewing of the membrane strain-time relationship. Differentiating equation 5.6 with
respect to x demonstrates that the nonlinear relationship between strain and platen
displacement is diminished when x >> (R - r):
de x
S x (R-r) (5.8)R,,,,, x+ +(R -r)
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The time variation of strain was computed for various cam sizes relative to the
hypothetical condition R = r (Figure 5.10).
I
N
z
Figure 5.10 Time course of membrane strain for cam displacement amplitudes of 3.1 mm (U), 5.4 mm
(A), 7.3 mm (X), 19.3 numm (). For each cam, data are normalized to the maximum strain yielded for
the hypothetical condition R = r (4).
5.3.7 Measurement of Strain Distribution.
The relationship between strain distribution and platen displacement was assessed
experimentally for both static and dynamic membrane deformations. For static
deformation, evaluation was performed using an open platen, identical in dimensions to
that in the strain device, which was mounted onto a microscope stage (Figure 5.11).
Thus, relative membrane displacements could be visualized both microscopically and
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macroscopically. Strains were assessed for static deformation of the membrane alone, the
matrix-coated membrane, and for cells grown on the membrane. For dynamic
deformation, membrane displacements were measured macroscopically only using a video
acquisition system capable of capturing 10 moving objects at a frequency of 10
images/sec.
i j
objective stage
Figure 5.11 Side view of platen for viewing cells microscopically under static strain.
deformed as dish is lowered manually into well and secured with locking collar.
Membrane is
For macroscopic measurement of membrane strain, dots were marked in ink on the
membrane in radial and concentric patterns. Relative membrane displacements were
obtained from photographs of the ink markings taken before deformation and in the
deformed configuration. For assessing microscopic strains, either on the matrix coating or
on the cells, fluorescent microspheres (Fluoresbrite, 1 gm diameter, Polysciences) were
suspended in culture media and allowed to settle onto the matrix or cell surface for 30
min. Unbound microspheres were eluted to leave a random array of microspheres. The
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microsphere displacements were derived from fluorescence photomicrographs taken
before deformation and in the deformed configuration; ink dot markings were used as
landmarks so that the identical aggregates of microspheres were photographed.
The membrane plane strain components were computed from either the dot or
microsphere displacements using the strain tensor (Figure 5.12). Consider a triad of
points (pl, P2, and p3) on a solid body constrained to deform in one plane. In the
undeformed configuration the point locations are described in the al-a2 rectangular
coordinate system, while in the deformed configuration these locations are represented in
the xl-x 2 coordinate system. By the geometric definition of distance, the change in
distance between two (pl, P2) of the three points is
dS2 -dS2 = dx,dx, -da i day (5.9)
in summation indicial notation. Expressing this equation in terms of the underformed
coordinate system al-a2,
dS2 -dS = 2eda,daj (5.10)
where
1 a3c, o2
ei , = I (8) - ) (5.11)
For computing the average strain based on markers a finite distance apart, the differentials
are approximated so that equation 5.9 becomes:
ASZ - AS° = 2eAaAaj (5. 12)
= 2(e,1 aa1 a, +2el2Aa 1 a 2 +e22 a a2 ) 2
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Thus the three independent plane strain components ell, e12, and e22, may be derived from
the three linearly independent equations from a triad of points.
a2 X2
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Figure 5.12 Method used to compute strain components from the relative planar displacements of a triad
of points.
5.3.8 Measurement of FGF-2 and IL-I a.
The release of FGF-2 or IL-la into the media was assessed quantitative
immunoassays (Quantikine Human FGF basic or Human IL-lo Immunoassay, R&D
Systems). Cell layers were subjected to three cycles of freezing and thawing to assess the
FGF-2 or IL-la remaining at the end of the experiment.
5.4 Results
5.4.1 Cellular Growth on Matrix-Coated Membrane
Growth of.human vascular smooth muscle cells and human dermal fibroblasts on
membrane was assessed for various concentrations of matrix coating. In initial
experiments, dissolved matrix was distributed on to the membrane and evaporated
overnight in a sterile hood. Membranes were coated with collagen at a density ranging
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from 0 to 100 lg/cm2, or with fibronectin at a density ranging from 0 to 10 pg/cm2. For
collagen and fibronectin, respectively, 20 pg/cm2 and 2.5 gg/cm2 coating densities were
optimal for adhesion, spreading, and growth of cells. Cell adhesion and spreading were
attenuated on matrix below these densities. Cells grew in overlapping sheets on matrix
coated at above the optimal densities, which would potentially create deviations between
membrane deformation and the actual deformation experienced by some cells.
Cells grew comparably on collagen-coated membrane, fibronectin-coated
membrane, or tissue culture plastic, but grew less efficiently on the collagen surface-
treated membrane from Flexcell (Figure 5.13). Although initial mechanical strain
experiments were performed with collagen-coated membranes, a rapid onset of retraction
and peeling of cells from the membrane was observed occasionally within two days of
plating. The process appeared similar to collagen gel contraction by smooth muscle
characterized in Chapter 2 and suggested that focal regions of the matrix-membrane
interface were disrupted by cellular contractile forces. Coating the membrane with
fibronectin overnight at 4' C, followed by aspiration, was found to be the most reliable
method for achieving cell anchorage. With this protocol, growth was dependent on the
coating density of fibronectin, reaching a maximum for 0.6 pg fibronecting/cm 2.
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Figure 5.13 Growth of human vascular smooth muscle cells on plastic (0), Silastic (U), Vitrogen-coated
Silastic (A), fibronectin-coated Silastic (V), and silicone membrane pre-coated with collagen (*). Cells
were plated on day 0 and media were changed on days 1, 2, and 3.
5.4.2 Sterilization of Membrane Dishes.
Although sterilization of membrane dishes with ethylene oxide gas did not initially
reveal toxicity, later experiments demonstrated cell death within days of plating.
Eventually, cell death occurred within 24 hours of plating and strongly suggested a toxic
process. Ethylene oxide can diffuse into and be adsorbed by certain plastics, and complete
liberation of the substance requires a long aeration period. Frequent gas sterilization of
120
these dishes apparently increased the latent concentration of ethylene oxide in the plastic
which presented a larger dose to the cultured cells. Although extending the aeration
period between sterilization and cell culture culture was a possible solution, the need for
ethylene oxide was eliminated altogether by machining new dishes out of the autoclavable
materials, polysulfone or Kynar.
5.4.3 Effect of Lubricant on Cell Morphology and FGF-2 Release.
In addition to the ethylene oxide sterilization, the lubricant used for the platen-
membrane interface was considered potentially toxic to cells. In preliminary experiments
FGF-2 was rapidly released from cells under mild mechanical strain; however, further
control experiments demonstrated the response to be induced primarily by Crisco. To
characterize this effect, Crisco was applied to half of the under surface of the membrane,
and cells were cultured on both halves of the top surface. Within 24 hours, cells on the
Crisco-coated half of the membrane became thinner and retracted relative to cells on the
control half. Media from cells on membrane coated with Crisco contained elevated
amounts of FGF-2 relative to media from cells grown on membrane without lubricant.
These observations strongly suggested that Crisco was diffusing across the membrane and
inducing morphological changes and release of FGF-2.
After screening several lubricants, Braycote 804 was found to be well suited both
biologically and mechanically (see next section). Cellular morphology was not affected by
Braycote 804 placed directly in the culture media. In addition, Braycote 804 on the
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undersurface of the membrane did not by itself induce FGF-2 release from cells (Figure
5.14).
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Figure 5.14 Effect of lubricants on the release of FGF-2 by human vascular smooth muscle cells. Cells
growing on membrane with an undercoating of Crisco (A) released FGF-2 during the first day, while cells
growing on membrane with Braycote 804 (M) or without lubricant (0) released no growth factor during
the four days. Error bars denote one standard deviation; n = 3 for each measurement.
5.4.4 Strain Distribution.
The normal and shear strain components were assessed for the membrane under
static platen displacement of 5.4 mm. The normal strains, ell and e22 , were approximately
equal to 6%, while the shear strain el2 was approximately equal to zero; strains were
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insensitive to either radial position (Figure 5.15A) or angular position (Figure 5.15B) on
the membrane. Thus deformation of the circular membrane by the circular platen was
associated with homogeneous and equi-biaxial strain, as predicted.
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Figure 5.15 The dependence of strain components et1 (@), el2 (E), and e22(A) on radial (A) and angular(B) location on membrane during static deformation (5.4 mm platen displacement). Data represent mean
+ sd for n = 4 to 6.
To assess the potential disruption of the matrix coating and/or disruption of cell
adhesion by dynamic deformation, the strain distribution was assessed for the collagen on
membrane, for the fibronectin on membrane, and for cells adhered to the collagen-coated
membrane. Membranes were first subjected to dynamic platen displacement of 5.4 mm at
1 Hz for 24 hrs. in an attempt to disrupt the membrane-matrix and/or matrix-cell
interfaces. Fluorescent microspheres were laid down on the membrane and photographed
in the undeformed state. The membrane was then statically deformed by a platen
displacement of 5.4 mm and then photographed at the previous locations. Strain
components derived from microspheres (Figure 5.16) on collagen (A), on fibronectin (B),
and on cells (C) were similar to those derived from ink markings on the membrane (Figure
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5.15A), and were independent of the radial position. Thus, no discontinuity in
deformation related to disruption of the membrane-matrix and matrix-to-cell interfaces
was observed. In addition, there were no obvious differences in cell morphology before
and after mechanical strain (5%, 1 Hz, 24 hr).
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Figure 5.16 The dependence of strain components ell (0), e12 (U), and e22(A) on radial location,
computed from the displacements of microspheres adhered to the collagen coating (A), the fibronectin
coating (B), and to cells on collagen-coated membrane (C) under static deformation (5.4 mm platen
displacement ). Data represent mean + sd for n = 4 to 6.
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Strain distribution in the membrane was also assessed for dynamic platen
displacement of different amplitudes. Strain components at maximum platen displacement
were independent of radial or angular membrane position, with equal normal strains and
shear strain equal to zero (Figure 5.17).
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Figure 5.17 The dependence of strain components e,1 (0) and e22 (0) on radial (A) and angular (B)
membrane location computed from the displacements of ink markings on membrane under dynamic
deformation (9.7 mm platen displacement amplitude). Data represent mean + sd for n = 4 to 6.
5.4.5 Clearance Between Dish Lid and Dish.
The membrane culture dish is essentially a vented chamber whose volume is
regulated by the membrane deformation. When the vent is small (lid sitting on dish),
deformation of the membrane increases the chamber pressure and expels a fraction of the
gas inside the chamber; upon relaxation of the membrane, the internal pressure decreases
relative to the atmosphere which causes the dish lid to sit firmly on the dish. This seal
prolongs the pressure decrease and delays the elastic recoil of the membrane. When an
offset clearance is maintained between dish lid and dish, the oscillatory circulation of the
humid gas in the boundary layer and the drier gas outside the dish may lead to convective
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loss of culture medium, particularly if the incubator is not saturated. When the incubator
environment ranged between 50-75% saturation due to routine opening (Figure 5.18),
media volume decreased with dynamic strain (10% amplitude, 1 Hz) dependent on the lid
configuration; after 8 hrs., media volume (15 ml initial volume) was greatest in a covered
control dish and lowest in an uncovered strained dish. The media loss relative to the
uncovered strained condition was decreased by maintaining a 0.1" spacer clearance
between the dish and lid, or by propping the lid on the adjacent collar screw, but was the
same as the loss from the closed, strained condition. The uncovered, control condition was
also associated a large loss of media. When the incubator door remained closed and the
humidity level was allowed to attain saturation (Figure 5.18, 8 - 24 hrs.), the rates of
evaporative loss decreased. Additional experiments performed for 24 hrs. with humidity
sustained > 85% demonstrated no significant evaporation of media (Figure 5.19). Thus,
saturated conditions should be maintained for dynamic strain experiments of longer than 1-
2 hrs. duration.
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Figure 5.18 Evaporation of culture media from dishes with different lid configurations with or without
membrane strain (1 Hz, 15%) as follows: uncovered + strain (0), uncovered - strain (U), propped lid +
strain (A), 0.1" lid clearance + strain (V), 0.1" lid clearance - strain (0), covered + strain (0), and
covered - strain (open A). Data represent mean for n = 2.
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Figure 5.19 Maintenance of media volume under dynamic membrane strain (15%, 0.5Hz, m) relative to
control (0) when incubator humidity is maintained > 85%. Data represent mean for n = 2.
5.4.6 Release of FGF-2 From Human Vascular Smooth Muscle Cells.
Mechanical strain induced the rapid release of FGF-2 in a strain magnitude-
dependent fashion (Figure 5.20). One hour after a single step or 10 impulses of strain
(55% amplitude), respectively, media contained 930 + 690 and 1100 + 330 pg/dish FGF-2
(vs. 60 + 40 pg/dish for control, p < 0.05); at 24 hours after the step and 10 impulse
strains respectively, media (A) contained 420 + 30 and 180 + 30 pg/dish FGF-2 (vs. 0 + 5
pg/dish for control), and the cell layers (B) contained 3440 + 370 and 6260 + 1180
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pg/dish FGF-2 (compared to 8450 + 2520 pg/dish for control). The decrease in media
FGF-2 with time suggests degradation and/or cellular re-uptake and metabolism of the
growth factor after mechanical release.
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Figure 5.20 A) Time course of FGF-2 in media. FGF-2 is released by human vascular smooth muscle
cells in response to a sustained step (0) and to 10 impulses (M) of strain at 55% magnitude relative to
control (A). B) FGF-2 remaining in the cell layers at 24 hours. Data represent mean + sd for n = 3 per
measurement.
FGF-2 was rapidly released also to a single impulsive strain, increasing with the
magnitude of strain (Figure 5.21); at 4 hr after strain of 15%, 25%, 40%, and 55%
magnitudes, respectively, media contained 440, 650, 1110, and 1580 pg/dish FGF-2
(compared to 10 pg/dish for control). Thus 15% amplitude impulse strain was sufficient
to induce release of the growth factor. Another experiment was performed to assess
whether impulsive strain at a lower amplitude, or cyclic dynamic strain at a lower
frequency, could also induce FGF-2 release (Figure 5.22). At 60 min. after a single strain
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impulse of 5% and 15% amplitudes, and dynamic strain (1 Hz) of 15% amplitude,
respectively, media contained 6 + 25, 260 + 30, and 240 + 30 pg/dish FGF-2 (compared
to 0 + 36 pg/dish for control). Thus, FGF-2 was not released by 5% strain, but was
released equally by 15% strain, either as a single rapid (< 150 msec, strain rate -
100%/sec) impulse or as -3600 cycles of lower frequency (strain rate - 30%/sec) strain.
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Figure 5.21 Time course of FGF-2 in media. FGF-2 is released by human vascular smooth muscle cells in
response to a single strain impulse of 15% (5), 25% (A), 40% (V), and 55% (*) magnitude relative to
control (0). Data represent measurement ofn = 2 pooled samples.
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Figure 5.22 Time course of FGF-2 in media. FGF-2 is released by human vascular smooth muscle cells
in response to single strain impulses of 5% (U) and 15% (A), and to continuous cyclic strain of 15% (V),
relative to control (0). Data represent mean + sd for n = 4.
5.4.7 Release of IL-la from Human Keratinocytes.
A similar experiment was performed to assess the potential release of IL-lx by
cyclic dynamic or impulsive strain (Figure 5.20). At 60 min. after a single strain impulse
of 40% impulse and after beginning cyclic strain (1 Hz ) of 15% amplitude, respectively,
media (A) contained 3170 and 110 pg/dish IL-la (compared to 68 pg/dish for control);
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90 min. later, the cell layers (B) contained 3290 and 20,500 pg/dish IL-la (compared to
20,100 pg/dish for control). Thus, IL-la was released in response to a single high
frequency, large amplitude strain, but not in response to sustained dynamic strain of lower
frequency and amplitude.
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Figure 5.23 A) Time course of IL-la in media. IL-lao is released from human keratinocytes in response
to a single impulse of 40% strain (A) and to continuous cyclic strain of 15% magnitude (0), relative to
control (0). B) IL-lo remaining in cell layer after 150 min. Data represent measurement of n = 3
pooled samples.
5.5 Discussion
Although smooth muscle cells within a three-dimensional matrix culture were
shown in previous chapters to be metabolically responsive to mechanical loading, the
cellular strains in these experiments were unknown and presumably non-uniform. Most
two-dimensional membrane "stretch" devices, while offering the advantage of cell
visualization, do not deliver spatially uniform strains.2,181 Frequency of oscillation can be
controlled with these devices, but as will be discussed in Chapter 6 (Discussion), both
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strain amplitude and strain rate vary with position on the membrane. Thus, a device was
developed to apply homogeneous and uniform biaxial strain to all cells on a flexible
membrane substrate. Design modifications to a previously used prototype device were
made to improve its operation, and technical obstacles related to sterilization, membrane
lubrication, and cell culture were addressed. In addition, membrane, matrix, and cellular
strains were verified to be homogeneous and biaxially uniform under static deformation.
In preliminary experiments, a single strain impulse induced the rapid release of FGF-2
from human vascular smooth muscle cells in a strain amplitude-dependent fashion.
Oscillatory strain (1 Hz, 150 min. duration) and impulsive strain (< 1 sec. Duration) of
15% amplitude induced comparable cellular FGF-2 release; however, FGF-2 was not
released during 5% oscillatory strain (1 Hz, 150 min. duration). In addition, impulsive
strain (40%, < 1 sec duration) induced the rapid release of IL-la from human
keratinocytes, but IL-la was not released in response to sustained oscillatory strain (1 Hz,
15%, 1 hr duration). Thus, certain features of cellular strain such as amplitude and rate
may control certain cellular responses.
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Chapter
6
Characterization of FGF-2 Release in Response to
Oscillatory Cellular Strain
6.1 Abstract
Although FGF-2 was released from cells in response to mechanical loading
(Chapter 4), the specific role of cellular deformation in FGF-2 release was not
characterized. To test the hypothesis that release of FGF-2 may be tightly regulated by
cellular strain, the device developed in the previous chapter was used to impose
controlled, homogeneous and uniform biaxial strain to human vascular smooth muscle
cells. Release of FGF-2 increased with the number of cycles of strain (15%, 1 Hz); 1, 9,
and 90 cycles of strain, respectively, released 0.55 + 0.06%, 2.9 + 0.3%, and 5.5 + 1.3%
of the total cellular FGF-2 (vs. 0.00 + 0.40% for control, p < 0.05 by ANOVA), but
release was not further increased for strain of 90 - 90,000 cycles. Mechanical release of
FGF-2 was dependent on the frequency of deformation; strain (90 cycles, 15%) at 0.25
Hz, 0.5 Hz, and 1 Hz, respectively, released 4.8 + 0.8%, 10.0 + 0.8%, and 14.0 + 1.2% of
the total FGF-2. Release was controlled also by the amplitude of deformation; strain (90
cycles, 1 Hz) at 5% amplitude released only 0.1 + 0.1% of the FGF-2, but strain at 15%
and 30% amplitudes, respectively, released 5.7 + 0.5% and 19.0 + 3.0% of the initial
growth factor (vs. 0.0 + 0.3% for control, p < 0.05), suggesting a strain amplitude
threshold for FGF-2 release. Injury to a sub-population of cells increased with the
frequency and amplitude of strain, as detected by propidium iodide or fluoresceinated
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dextran, but cells were not injured by strain below 10% amplitude. Strain following
heparin treatment released 12.6 + 1.6% of the total FGF-2 (vs. 15.8 + 0.9% for strain
alone, p < 0.05), suggesting that most FGF-2 was liberated from the nuclear or
cytoplasmic pools. Conversely, strain (15%, 1 Hz) in the presence of heparin released
25.2 + 3.5% of the total FGF-2 (vs. 15.6 + 2.6% for strain alone, p < 0.05). These data
suggest that the frequency and amplitude of cellular -strain tightly regulate the release of
intracellular FGF-2. In addition, mechanical strain causes a transfer of intracellular FGF-2
to the extracellular low-affinity receptors.
6.2 Introduction
Mechanical forces may regulate cellular function in physiological and pathological
states. Vascular cells are subjected to a dynamic mechanical environment modulated by
pulsatile pressure and oscillatory shear forces. The accompanying stresses may regulate
normal vascular tonel82 and contribute to atherogenesis,183 the vascular hypertrophy
associated with hypertension, 184 and the acute rupture of atherosclerotic lesions.37' 85 The
mechanical forces associated with certain therapeutic interventions also may induce
important biological responses. Coronary balloon angioplasty, a common treatment for
occlusive vascular disease, imposes extreme vessel wall strains which may play a major
role in triggering restenosis.'30 ' 18 6
Fibroblast growth factor-2 (FGF-2) may participate in the early smooth muscle
cell migratory and proliferative responses of restenosis.48 FGF-2 is a potent mitogen and
chemotactic factor for endothelial cells and vascular smooth muscle cells, and is
synthesized by these and a variety of other cells.43 ,166,167 ,187 FGF-2 may be synthesized in
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multiple forms 8 "'8 9 which are differentially distributed in the cytoplasm and nucleus. 190 '193
FGF-2 may bind to receptors on a broad range of target cells to regulate growth,
differentiation, tissue regeneration, and angiogenesis. However, despite its apparent
extracellular mode of action, FGF-2 is not found in vesicles 187 and does not have a
classical hydrophobic leader sequence for secretion by the exocytotic pathway. 172
FGF-2 has been shown to be released from cells in vitro by cytosolic leakage
through injured cell membranes.160,194-196 Biochemical stimuli' 97' 98 and also mechanical
trauma, such as scraping 160 and crushing 199 have been shown to induce FGF-2 release
from cultured cells. Wounding by needle puncture causes skeletal myofibers to release a
variable amount of FGF-2 which correlates with the frequency of membrane
disruptions.162 However, healthy cells under little or no mechanical stimulus also may
release FGF-2. In cultured endothelial cells, basal levels of protease production and DNA
synthesis are inhibited by neutralizing antibodies to FGF-2. Physiological activities such as
contraction of cardiac myocytes " and migration of endothelial cells200 induce FGF-2
release, suggesting that neither cell death nor extreme injury is a prerequisite for release.
Once released, FGF-2 may bind not only to specific cell surface receptors, but also
with lower affinity to heparan sulfate proteoglycans and other pericellular matrix
components.' 73'20' These low-affinity, non-signaling receptors are thought to enhance
growth factor activity20 2 by raising local growth factor concentrations, promoting receptor
binding203, or by other mechanisms. The matrix may also serve as a FGF-2 reservoir
which may be released rapidly under certain conditions 204207.
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Although FGF-2 can modulate a variety of cellular functions in vitro, the function
of this growth factor in physiological and pathological states is unclear, in part, because
the regulation of its release is incompletely understood. The ability of a broad range of
mechanical stimuli to induce release of FGF-2 in vitro suggests that FGF-2's release and
function in vivo may vary with local mechanical conditions. Many cells that synthesize
FGF-2 also experience strain in vivo; depending on the type of cell and anatomic location,
these strains may be cyclical or intermittent, short or long in duration, rapid or slow in
onset. In addition, as discussed in Chapters 1 and 3, strains in neighboring cells may be
widely variable depending on their orientation. Thus, understanding the specific role of
mechanical strain in FGF-2 release may help elucidate the function of this growth factor.
Additionally, the relative roles of the matrix and intracellular reservoirs of FGF-2 have not
been characterized for a mechanical stimulus. In the experiments of Chapter 4, the release
of FGF-2 was observed in response to a transient mechanical compression of a three-
dimensional smooth muscle cell-collagen matrix culture.208 The induction of DNA
synthesis was dependent on the magnitude of the compressive strain, but the dependence
of FGF-2 release on cellular deformation, the extent of cellular injury, and the role of
extracellular FGF-2 binding could not be readily assessed.
The preliminary experiments in Chapter 5 demonstrate the release of FGF-2
following either oscillatory strain of moderate frequency and magnitude or a single
impulsive strain; mechanical release to the latter stimulus was also amplitude-dependent.
In this chapter, human vascular smooth muscle cells cultured in monolayer were subjected
to uniform biaxial mechanical strain to address the following hypotheses: 1) brief
oscillatory mechanical strain induces rapid release of FGF-2; 2) release of FGF-2 and
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cellular injury depend on the amplitude, frequency, and the number of cycles of the
mechanical strain; 3) FGF-2 is released primarily from the intracellular pool; and 4) once
released, part of the FGF-2 is sequestered by the extracellular receptor compartment.
6.3 Materials and Methods
6.3.1 Cell Culture
Human vascular smooth muscle cells were derived from explants of discarded
portions of saphenous veins obtained during coronary bypass surgery performed at
Brigham and Women's Hospital. Smooth muscle cells were cultured in DMEM with 10%
FCS at 370C and 5% CO2. These conditions are selective for growth of smooth muscle
cells over endothelial cells. 143 The explant and culture methods were identical to those
used in previous studies of cultured vascular smooth muscle cells.' 44" 145 Cells were
cultured through passages 3 through 5 before transfer to membrane dishes for use in
mechanical strain experiments. Sterilized membrane dishes were coated with human
plasma fibronectin (Gibco) overnight, washed with PBS, and plated with cells at a density
of 5x103 cells / cm2. Cells were incubated overnight in DMEM supplemented with 10%
FCS to permit adhesion and spreading. For serum-free conditions, cells were washed
twice with DMEM and cultured for -24 hours in defined, seruni-free IT medium (equal
volumes of DMEM and Ham's F-12 supplemented with 1 p.mol / L insulin and 5 Rpg / mL
transferrin). Before the experiment, serum-free medium was again changed to minimize
residual growth factors.
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6.3.2 Application of Mechanical Strain.
Oscillatory, homogeneous and equibiaxial strain was applied to cells on
fibronectin-coated membranes at frequencies ranging from 0.1 to 1 Hz and at amplitudes
of- 5%, 10%, 15%, and 30%. The design of the membrane strain device, theoretical
relationships between platen displacement and membrane strain, and experimental strain
validations obtained for the membrane, matrix, and cells are presented in the previous
chapter. Control parallel dishes received no mechanical strain but were otherwise treated
in identical fashions.
6.3.3 Measurement of FGF-2.
To evaluate the time course of FGF-2 release, media aliquots were collected at
various times after beginning strain. At the end of the experiment, the combined
intracellular and receptor-bound FGF-2 was harvested with 2 M NaCI, pH 7.5 and three
cycles of freeze/thaw. In some experiments, the cell layer was eluted with 2M NaCI, pH
7.5 and 2M NaCl, pH 4.0 to harvest FGF-2 bound to the low- and high-affinity receptors,
respectively. 209 211 Alternatively, FGF-2 bound to the low-affinity receptors was harvested
by treatment with heparan sulfate, heparitinase,'73 or heparin 212 Media, elutions, and cell
lysates were assayed for FGF-2 with a quantitative enzyme immunoassay (Quantikine
Human FGF basic Immunoassay, R&D Systems).
6.3.4 Measurement of Cellular Injury.
To evaluate the acute detachment of cells from the culture substrate, cell adhesion
was measured before and immediately after strain. Cellular nuclei were stained with
acridine orange (2 gpg/mL, Sigma) and photographed under fluorescence microscopy at
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random locations marked on the underside of the membrane. Cells were subjected to
mechanical strain and re-photographed at the identical locations.
To assess plasma membrane integrity, cells were subjected to mechanical strain and
stained with propidium iodide and fluorescein diacetate (10 pg/mL, Sigma) for several
minutes. Propidium iodide and fluorescein diacetate staining has been used previously to
identify injured cells and are more sensitive markers than lactate dehydrogenase
release.213' 214 Alternatively, plasma membrane disruption was detected by fluorescein
dextran uptake, which has been used previously to assess cell injury in the context of FGF-
2 release. 160,162,' 95 Before mechanical strain, cells were changed to serum-free media with
fluoresceinated dextran (10,000 MW, 2.5 mg/mL, Sigma). Cells were subjected to
mechanical strain, incubated for 10 minutes, and washed twice with PBS. After labeling
with either method, cells were photographed under fluorescence microscopy at several
random membrane locations.
6.3.5 Immunofluorescence
Cells were washed with PBS, fixed with 2% paraformaldehyde for 10 minutes, and
permeabilized with 0.1% Triton X-100 for 2 minutes. They were incubated in blocking
buffer (20% goat serum) and then changed to the primary anti-human FGF-2 antibody (10
p~g/ml, Upstate Biotechnology) for 1 hr. Cells were washed with PBS and incubated with
the secondary, anti-mouse IgG antibody conjugated to Rhodamine (Sigma) for 1 hr. After
washes in PBS, cells were rinsed and allowed to air dry.
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6.3.6 Statistics.
Data are presented as mean + one standard deviation or are measurements of
pooled samples. Comparison among several groups of continuous variables was
performed using analysis of variance. For comparison between specific groups of
continuous variables, the two-sample Student's t test was used. A p value < 0.05 was
considered statistically significant. The findings reported below are representative of
results of at least two independent experiments.
6.4 Results
6.4.1 Release of FGF-2 During Dynamic Strain.
Continuous, oscillatory mechanical strain (1 Hz, 15%) of human vascular smooth
muscle cells induced the rapid release of FGF-2 (Figure 6.1); after 10 min. of strain, media
contained 3.2 + 0.2% of the total initial cellular FGF-2 (vs. 0.3 + 0.2% for unstrained
control, p < 0.005 ); after 30 min, media contained 3.5 + 1.2% of the total FGF-2 (vs. 0.4
+ 0.2% for control, p < 0.005); and after 60 min., media contained 3.8 + 1.1% of the total
FGF-2 (vs. 0.3 + 0.3% for control, p < 0.001). The total initial cellular FGF-2 in each
dish was estimated as the combined media and cell-associated (intracellular and receptor-
bound) FGF-2 at the end of the experiment. Additional experiments were performed to
assess the dependence of release on components of the mechanical strain.
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Figure 6.1. Cumulative FGF-2 in culture media during continuous oscillatory strain (1 Hz, 15%
amplitude, 0) of human vascular smooth muscle cells, relative to control (0). Data represent mean + sd
for n=3 to 7.
6.4.2 Dependence of FGF-2 Release on Characteristics of Strain.
Release of FGF-2 increased with the number of cycles of mechanical strain (Figure
6.2); 60 min. after one cycle of strain (1 Hz, 15% amplitude), media contained 2.9 + 1.5%
of the total initial cellular FGF-2 (vs. 0.9 + 0.4% for unstrained control, p = NS by
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ANOVA); for 9 cycles of strain, media contained 4.8 + 0.4% of the total FGF-2 (p < 0.05
vs. control); for 90 cycles, media contained 7.8 + 0.7% of the total FGF-2 (p < 0.005 vs.
one cycle). Mechanical strain of greater than 90 cycles released no additional FGF-2; after
900 cycles and 3600 cycles of strain, respectively, media contained 7.2 + 1.2% and 6.2 +
0.9% (p = NS vs. 90 cycles) of the initial total cellular FGF-2, suggesting a limited
releasable FGF-2 pool for a given combination of strain frequency and amplitude. In a
separate experiment, cells were exposed to strain (1 Hz, 15% amplitude) of either 90
cycles or -90,000 cycles and were changed to fresh media at 150 min. after beginning
strain (Figure 6.3); cumulative FGF-2 in the media increased with time before the media
change, but decreased to baseline control thereafter. Thus, FGF-2 was rapidly released to
either brief (- 1 min) or sustained (-24 hr) oscillatory strain, but release did not continue
after 150 min. Thus, further characterization of FGF-2 release was performed primarily
for 90 cycles of strain.
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Figure 6.2. Dependence of FGF-2 release from human vascular smooth muscle cells on the number of
cycles of mechanical strain (1 Hz, 15% amplitude). Relative to control (0), cumulative FGF-2 in the
media increased with cycle number for 1 cycle (M), 9 cycles (A), and 90 cycles (V) of strain (1 Hz, 15%
amplitude); however, FGF-2 was not further increased for 900 cycles (*). Data represent mean + sd for
n=3.
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Figure 6.3. Acute FGF-2 release from human vascular smooth muscle cells in response to both brief and
prolonged dynamic strain. Relative to control (0), strain (1 Hz, 15%) of 90 cycles (0) and 90,000 cycles
(A) initiated at t=0 min. were associated with rapid increases in FGF-2 in the media; however, FGF-2 was
not further released after change to fresh media at t=150 min. Data represents measurement of n = 3
pooled samples.
Cyclic strain at 15% amplitude induced FGF-2 release in a frequency-dependent
fashion (Figure 6.4); 60 min. after beginning strain (90 cycles, 0.25 Hz), media contained
4.8 + 0.8 % of the total initial cellular FGF-2 (vs. 0.4 + 0.6% for control, p < 0.01 by
ANOVA); for strain at 0.5 Hz, media contained 10.4 + 0.8% of the total FGF-2 (p <
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0.001 vs. 0.25 Hz); for strain at 1 Hz, media contained 13.8 + 1.2% of the total FGF-2 (p
< 0.05 vs. 0.5 Hz). Mechanical release of FGF-2 was also dependent on the amplitude of
strain (1 Hz) (Figure 6.5); 60 min. after beginning strain (90 cycles, 5%) amplitude, media
contained 0.1 + 0.1% (vs. 0.0 + 0.1% for control, p = NS) of the total initial cellular FGF-
2; for strain at 15% amplitude, media contained 5.7 + 0.5% (p < 0.05 vs. 5% amplitude);
for strain of 30% amplitude, media contained 18.9 + 2.7% (p < 0.001 vs. 15% amplitude).
Another experiment was performed to characterize the apparent amplitude threshold for
FGF-2 release (Figure 6.6); 90 cycles (1 Hz) at 15% amplitude strain induced rapid
release of FGF-2 within 150 min., while 90,000 cycles at 5% amplitude induced little
release throughout the 24-hr period.
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Figure 6.4. The dependence of release of FGF-2 from human vascular smooth muscle cells on the
frequency of mechanical strain (90 cycles, 15% amplitude). Relative to control (0), cumulative FGF-2 in
media increased with frequency for 0.25 Hz (U), 0.5 Hz (A) , and 1 Hz (Y). Data represent mean + sd
for n=3.
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Figure 6.5. The dependence of FGF-2 release from human vascular smooth muscle cells on the amplitude
of mechanical strain (90 cycles, 1 Hz). Relative to control (0), cumulative FGF-2 in media did not
increase for 5% amplitude strain (M) but increased with amplitude for 15% (A) and 30% (V) strain.
Data represent mean + sd for n = 3.
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Figure 6.6. The release of FGF-2 from human vascular smooth muscle cells by mechanical strain above
and below 10% amplitude. Relative to control (0), 90 cycles of 15% strain (0) induced rapid release of
FGF-2, but 90,000 cycles of 5% strain (A) caused no release. Data represents measurement of n = 3
pooled samples.
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6.4.3 CellularlInjury.
To evaluate the possibility that the increase in FGF-2 in the media was caused
simply by acute detachment of cells from the membrane during the mechanical strain, cell
detachment was compared to the percentage of total cellular FGF-2 released. After
mechanical strain (90 cycles, 1 Hz, 15%), the fraction of cells that had detached (0.7 +
1.1%) was small compared to the fraction of FGF-2 released (11.5 + 0.6%, p < 0.001).
Thus, approximately 90% of the FGF-2 in the media was derived from the intact cell layer.
In the experiments of Chapter 4, cellular injury was not detectable by lactate
dehydrogenase or total DNA. In this study, cellular injury by mechanical strain was
detected by dual staining with fluorescein diacetate and propidium iodide. Propidium
iodide stains the nuclei of injured cells by diffusing through disrupted plasma membranes,
while fluorescein diacetate stains intact plasma membranes of healthy cells; together, these
markers have been shown to be more reliable than either lactate dehydrogenase or trypan
blue exclusion in the assessment of cell injury. 214,215 Mechanical strain led to increased
propidium iodide staining of a sub-population of cells distributed diffusely on the culture
membrane. The percentage of propidium iodide-stained cells increased with the frequency
of mechanical strain (90 cycles, 30%) and with the amplitude of strain (90 cycles, 1 Hz)
(Data not shown). This amplitude-dependence of cellular injury was also detected by
dextran uptake (Figure 6.7); because dextran is retained only by cells whose membranes
have resealed, 160,162,216 these observations suggest transient, sublethal injury to cellular
strain.
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Figure 6.7. Dependence of cellular injury on mechanical strain. Fluoresceinated dextran uptake by cells
for control and after 15%, and 30% amplitude strain (90 cycles, 1 Hz).
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6.4.4 Role of Matrix Reservoir in FGF-2 Release.
Heparin-like molecules and certain matrix degradative enzymes have been shown
to either release FGF-2 pre-bound to the low-affinity receptors or compete with these
receptors for binding of free FGF-2 173; in control experiments, treatment of quiescent
smooth muscle cells by heparin, heparitinase, or heparan sulfate caused comparable release
of FGF-2 (- 1% of the total) into the media (data not shown). To evaluate the relative
contributions by the intracellular and the low-affinity receptor FGF-2 pools to the
mechanical release of FGF-2, cells were pretreated with heparin (5 ptg/ml) before
mechanical strain. Heparin treatment released less than 1% of the total cellular FGF-2
(Figure 6.8). Mechanical strain (90 cycles, 30%, 1 Hz) after heparin treatment released
12.6 + 1.6% of the total initial cellular FGF-2 (vs. 15.8 + 0.9% for strain alone, p < 0.05).
Thus, most FGF-2 was released into the media from the nuclear or cytoplasmic pools and
not from the low-affinity receptors.
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Figure 6.8. Effect of pre-treatment with heparin on FGF-2 release from human vascular smooth muscle
cells in response to mechanical strain. FGF-2 in the media is increased in media by heparin treatment
(second column). Strain (90 cycles, 1 Hz, 30%) after heparin pre-treatment caused release of FGF-2
(third column) that was less than that caused by strain alone (fourth column).
To assess the amount of FGF-2 that is sequestered by the low-affinity receptors
after mechanical release, cells were exposed to strain (90 cycles, 30%, 1 Hz) and
incubated with heparin (5 pg/ml) to block receptor binding of the FGF-2 as it was being
released. After 60 min., media with and without heparin, respectively, contained 25.2 +
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3.5% and 15.6 + 2.6% (p < 0.05) of the total initial cellular FGF-2 (Figure 6.9).
Conversely, parallel cells were exposed to strain, incubated for one hour, and treated with
fresh, heparin-supplemented media to liberate any FGF-2 that was potentially transferred
by mechanical strain to the low-affinity receptors. Media with and without heparin,
respectively, contained 11.0 + 0.7 and 4.2 + 0.1% (p < 0.001) of the total initial cellular
FGF-2. Thus, approximately one-third of the mechanically released FGF-2 was
subsequently bound to the low-affinity receptors. In addition, the relative distribution of
released FGF-2 to the extracellular media and receptor pools was dependent on the
amplitude of strain (90 cycles, 1 Hz); mechanical strain of 5% amplitude transferred no
intracellular FGF-2 to either the media or receptors (Figure 6.10); 15% strain released
FGF-2 that was distributed approximately equally to the media and receptors; 30% strain
led to a three-fold increase in media FGF-2 with no additional transfer to the receptors
beyond that associated with 15% strain, suggesting saturation of the receptor pool by
15%strain.
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Figure 6.9. Ability of heparin to increase FGF-2 in the culture media after mechanical strain. Human
vascular smooth muscle cells were subjected to strain (90 cycles, 1 Hz, 30%) or received no mechanical
strain and further incubated in the presence or absence of heparin (5 J.g/mL). After 60 min. FGF-2 in the
media was increased by heparin treatment (column 2). Strain in the presence of heparin (column 4)
released a greater amount of FGF-2 than strain alone (column 3). Data represent mean + sd for n = 3.
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Figure 6.10. Transfer of FGF-2 to media and low-affinity receptors by mechanical strain of 5%, 15%, and
30% amplitude. FGF-2 in the media 60 min. after mechanical strain (90 cycles, 1 Hz) in the presence
(black column) or absence (gray) of heparin (5 ýLg/ml). After 5% strain (second pair of columns), FGF-2
was not increased in the media (gray column) or low-affinity receptor pool (difference between gray and
black columns). Strain of 15% amplitude (third pair of columns) increased FGF-2 in both the media and
receptor pool; however strain of 30% amplitude (fourth pair of columns) caused further increase of FGF-2
in the media only. Data represent mean + sd for n = 3.
6.4.5 Localization of Release.
Immunofluorescence staining for FGF-2 in basal control human vascular smooth
muscle cells revealed nuclear and cytoplasmic FGF-2 pools; control staining conditions
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demonstrated the nuclear staining was specific. Although, staining of the nucleus was
more intense than of the cytoplasm, the relative intracellular distributions are difficult to
assess from staining intensity. To localize the mechanical release of intracellular FGF-2,
cells were stained for FGF-2 after strain (90 cycles, 1 Hz, 15%) and incubated for 60 min.
with heparin. FGF-2 staining was less intense in the strained cells, particularly in the
nuclei, than in the unstrained control cells; however, staining intensity was consistent
among neighboring cells on the same membrane. Thus, mechanical release of FGF-2 may
involve a transfer of FGF-2 both from nucleus to cytoplasm and from cytoplasm to the
extracellular pools. Although the staining is consistent with FGF-2 being released
uniformly from cells (in contrast to the cell injury distribution), the localization of release
can only be assessed with more accurate quantification of the nuclear and cytoplasmic
FGF-2 pools before and after strain.
6.5 Discussion
Although FGF-2 is an ubiquitous cytokine which can mediate a variety of cellular
responses in vitro, the regulation of its release and thus the importance of this angiogenic
growth factor in vivo is incompletely understood. FGF-2 has been referred to as a
"wound hormone" by McNeil and colleagues, who made the important observation that
FGF-2 is released by mechanical injury to cells. Studies by that group 11,161,162 and others
demonstrate cellular release of FGF-2 by both overt trauma and mild mechanical stimuli,
suggesting that FGF-2 may serve important but potentially different roles in physiologic
and pathologic states.
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The present data demonstrate tight control of FGF-2 release by cellular strain and
are summarized as follows. First, release of FGF-2 was regulated by a strain-amplitude
threshold. At amplitudes below 10%, prolonged (-105 cycles at 1 Hz) oscillatory strain
did not cause release of FGF-2; however, brief (~102 cycles) oscillatory strain above 10%
amplitude induced rapid release of the growth factor. Second, when strain exceeded 10%
amplitude, FGF-2 release increased with the amplitude. Third, release of FGF-2 increased
with the frequency of strain. Fourth, release increased with the number of cycles of strain
but was maximal for a relatively brief stimulus (102 cycles, 1 Hz). FGF-2 release began
within 5 minutes of the onset of strain and was complete within - 150 minutes even for
prolonged (105 cycles) of oscillatory strain. Taken together, these data suggest that
sustained oscillatory cellular strain above an amplitude threshold induces an acute FGF-2
release response. Additionally, FGF-2 release does not continue with repeated cycles of
strain, but rather the response is finite and determined specifically by the frequency and
amplitude of the early (102 cycles) mechanical stimulus.
The rapid and finite nature of the FGF-2 release response to cellular strain is
consistent with a cell injury-mediated mechanism. Cellular injury occurred in parallel with
FGF-2 release; a sub-population of cells was injured for strain above an amplitude
threshold of 10%, and increased with the amplitude and frequency of strain. One
interpretation of these observations is that cellular injury is determined independently by
the strain amplitude and frequency. Alternatively, cellular injury may be determined by a
single parameter, the strain rate. It is important to distinguish frequency of strain from
strain-rate; for sinusoidal strain oscillation (e = esinot), the strain rate is a sinusoidal
function whose amplitude depends on both frequency and the amplitude of strain (de/dt =
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eocoscot). Thus, in the experiments assessing amplitude dependence, the strain amplitude
was not changed without also changing strain rate; amplitude dependence could be tested
by adjusting the frequency accordingly to maintain a constant strain rate amplitude.
Injury to astrocytes by a single strain impulse of constant magnitude increases with the
strain rate. 213 Mechanical failure of engineering construction materials is typically a
function of the amplitude, strain rate, and number of cycles of strain.
Cells subjected to external mechanical manipulation, such as scraping'6 1 , 95 or
puncture, 162 suffer transient resealable cell membrane disruptions through which FGF-2
may be released. Our experiments demonstrate that cellular perturbation via the
underlying culture substrate induces a transient increase in cell membrane permeability.
162,217 Although plasma membrane disruptions were not localized, one possible scenario is
that mechanical failure occurs near integrins at focal adhesions as they transmit forces
from the underlying matrix.82' 218'219 The process may be similar to the disruption and
detachment of focal adhesions observed at the trailing edge of migrating cells; 220
migration is associated with release of intracellular FGF-2 possibly through permeabilized
cell membranes.200
In addition to the intracellular FGF-2 pool, the extracellular receptor-bound FGF-2
also was hypothesized to be a potential source of mechanically releasable growth factor.
FGF-2 binds to both high affinity signaling receptors and with lower affinity to heparan
sulfate and other cell surface proteoglycans 20 1'202 These low-affinity receptors may serve
potentially as a high capacity reservoir for FGF-2 which may be released by enzymatic
degradation 20 4,207 . Binding of the low-affinity receptors to free FGF-2 may be
competitively inhibited by heparin and heparin-like molecules. In these experiments,
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treatment with heparin, heparan sulfate, or heparitinase demonstrated release of FGF-2
primarily from the intracellular compartment, with only a small fraction arising from the
low-affinity receptor binding. It is important to note that the relative baseline intracellular
and extracellular distributions of FGF-2 may be altered by cell density or other culture
conditions.212 In addition, the monolayer cell culture may not adequately simulate FGF-2
binding to and potential mechanical release from a three-dimensional matrix in vivo.
The low-affinity receptors are required for some FGF-induced biological responses
and may help stabilize, 221 present, and promote binding of the growth factor to the high-
affinity signaling receptors. 2  Subsequent dimerization of the high-affinity receptors may
also depend on interactions with these proteoglycans. 222 Another function of the low-
affinity receptors may be to minimize FGF-2 diffusion away from the site of release.202
Previous studies suggest the potential for the level of FGF-2 in the culture medium to
underestimate total FGF release.200' 208 In this study, mechanical strain induced the transfer
of FGF-2 from the intracellular cytoplasmic pool to the extracellular receptors. In
response to mechanical strain of 15% amplitude, the majority of the released FGF-2 was
distributed to the receptors; FGF-2 released by 30% strain saturated the receptors and was
partially distributed to the culture medium. Thus, the low-affinity receptors can increase
the effective concentration of the growth factor near the site of release, presumably
enhancing the probability of interactions with the high affinity receptors. The role of cell
surface proteoglycans in concentrating FGF-2 near the site of injury may be particularly
important for targeting appropriate angiogenic responses. 223 In addition, the properties of
the mechanical strain may determine the extent to which the released FGF-2 may diffuse
to more distant target cells.
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The dependence of FGF-2 release on mechanical strain suggests a potential model
for the regulation of FGF-2 release in physiologic and pathophysiologic vascular states.
Under long-term, oscillatory deformation, vascular smooth muscle cells may synthesize
and maintain an intracellular FGF-2 pool of which little is released. This reservoir remains
intact and is depleted only when cellular strain exceeds an amplitude threshold. Under
conditions of elevated heart rate or of mechanical stress such as hypertension or at focal
regions of atherosclerotic plaque,37,46,47 the strain rate may be sufficient to injure a subset
of cells which then rapidly release FGF-2. Under conditions of extremely high mechanical
strain such as during balloon angioplasty, a majority of cells may be injured, releasing a
large amount of FGF-2.
Interestingly, neighboring cells exposed to nearly identical membrane substrate
strain were nonuniformly injured, reflecting possible differences in intracellular strains.
Vascular smooth muscle exposed to biaxial deformation experience higher local strains in
the pseudopods than in the cell body. 224 Because the strain profile in a given cell under
these experimental conditions may depend on its particular cytoskeletal arrangement and
focal adhesion distribution, sensitivity to injury may be variable within a population of
cells. The sensitivity to injury and the potential release of FGF-2 by mechanical strain may
also be cell type-specific. Additional studies with other cell types may further clarify the
functions of FGF-2 in different conditions in vivo.
Responses to mechanical loading have been studied in vascular smooth muscle and
other types of cells using a variety of devices. Mediated by various signal transduction
mechanisms, 54 ,149,182,225 the observed responses include early gene induction,'
51,226
proliferation, 71'22 7'228 morphologic changes,229'230 matrix metabolism, 73' 74 and release of
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growth factors and other cytokines.' 99 Despite the diversity of these responses, the
experiments of this chapter imposing a homogeneous and uniform biaxial strain to all cells
within a culture well suggest that specific components of the applied strain may be critical
regulatory parameters. Previous studies that apply an oscillatory but spatially
nonhomogeneous cellular strain, while precisely controlling the frequency of oscillation,
do not control either the strain amplitude or the strain rate. Under such conditions, the
precise mechanical control of a cellular response may be difficult to discern if the response
is strain amplitude- or strain rate-dependent. In addition, the observed response may not
be directly controlled by mechanical strain but may be modulated in a paracrine fashion by
a second co-existing strain amplitude- or strain rate-dependent response such as FGF-2
release. Thus, the application of uniform mechanical stimulation may be critical for
understanding the regulation of certain mechanoresponses.
This study may have potential implications for the clinical management of
atheroma. Current treatment of atherosclerotic lesions by balloon angioplasty is often
followed by late restenosis, 130,231 and animal models of vascular injury suggest that intimal
thickening is dependent on the severity of vascular injury and the magnitude of FGF-2
release.48  The amplitude and frequency-dependence we have observed suggest that
smooth muscle cell injury and FGF-2 release after angioplasty may be regulated by the rate
and magnitude of vascular dilation. Thus, further understanding the dependence of injury
on the rate and number of inflations as well as the balloon size may help improve
angioplasty strategies.
In conclusion, this chapter summarizes experiments performed to further
characterize FGF-2 release by human vascular smooth muscle cells under mechanical
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deformation and addresses some of the questions raised in Chapter 4. FGF-2 release was
dependent on the frequency, amplitude, and number of cycles of mechanical strain. Injury
to a sub-population of cells randomly distributed on the membrane was detected
immediately after brief dynamic strain using methods more sensitive than those used in the
previous chapter. Although the extracellular low-affinity receptors were not a major
source of mechanically released FGF-2, these receptors effectively sequestered growth
factor after release.
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Chapter
7
Conclusions
7.1 Summary of Experiments: Relevance to Disease
7. 1.1 Reorganization of Matrix
The experiments of Chapter 2 assessed the mechanical influence of vascular
smooth muscle cells on their surrounding matrix. While adhesion to collagen was
mediated by two (atf 1, a2 31) of the four 01 integrins expressed by these cells. However,
contraction and reorganization of a three-dimensional collagen matrix depended on only
the &a21 integrin. In addition, an anti-01 antibody known for its stimulatory effect on
collagen adhesion was found to inhibit gel contraction, suggesting that reorganization of
matrix involves a dynamic cycling of integrin-matrix interactions, perhaps similar to
integrin-mediated cell migration.220'232 These results suggest that smooth muscle cells in
vivo participate in tissue remodeling through the function of specific integrins. Selective
targeting of integrin-matrix interactions, through local delivery of antibodies or peptides,
may be a useful strategy for modulating early remodeling activities in atherosclerosis and
other diseases.233' 234
7.1.2 Mechanical Response in Three-dimensional Matrix
In addition to mechanically altering the collagen matrix, vascular smooth muscle
cells were also metabolically responsive to mechanical loading of the matrix. Static
compression of vascular smooth muscle cell-collagen gel cultures decreased DNA and
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glycosaminoglycan synthesis. Although the mechanism for decreased biosynthesis was not
assessed, one possibility may be related to the general inhibition of cellular activity by a
three-dimensional matrix. 38' 88'92'93,"00,235 Gel compression in these experiments may have
decreased the cellular responsiveness to growth factors by increasing the matrix
concentration. 94 In addition, these data suggest that elevated arterial pressure would
inhibit cellular proliferation and matrix synthesis, despite the accelerated medial
hypertrophy observed with hypertension. This apparent discrepancy might be accounted
for by numerous factors, including the absence of a superimposed oscillatory deformation
in the compression experiment.
A single, brief transient compression of the gel cultures caused an FGF-2-
mediated, delayed induction of DNA synthesis that was dependent on the magnitude of
imposed gel strain. This mechanical loading is qualitatively similar to vessel dilation
during balloon angioplasty. Althoug the participation of FGF-2 in intimal smooth muscle
hyperplasia has been demonstrated in vivo, this thesis assessed the specific role of smooth
muscle cell responses to mechanical strain. Interestingly, only part of the DNA synthetic
response appeared to be mediated by FGF-2. There was a dose-dependent inhibition of
compression-induced DNA synthesis by a monoclonal antibody against FGF-2, but only
partial inhibition was achieved. In addition, the concentration of FGF-2 measured in
conditioned media after compression was not sufficient to induce a DNA synthetic
response when added exogenously to control cells. PDGF has been shown to participate
in growth responses to mechanical loading,71"99 but was not found to play a role in our
experiments.
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Surprisingly, cellular injury was not detected in association with transient
compression. Previous studies have demonstrated FGF-2 release by cellular injury; FGF-2
lacks a secretory leader sequence and is distributed diffusely in the cytoplasm, and a cell
injury-release model is consistent with the vascular injury associated with restenosis
models. However, due to a number of factors, the possibility of cell injury by transient
gel culture compression could not be excluded. Lactate dehydrogenase and total DNA
content were, at best, crude markers of cell death. Thus, focal cell death or generalized
sublethal cell injury, as has been associated with FGF-2 release, 160 195 might not be
detected by these methods. The presence of the three-dimensional matrix created a couple
obstacles. The potential for matrix to bind FGF-2 suggested that the level of FGF-2
measured in the media might underestimate the magnitude of FGF-2 released and the
extent of cell injury. In addition, the optical opacity of the dense matrices prevented
visual assessment of cell morphology.
7.1.3 Role of Cellular Strain.
The experiments of the Chapters 3 and 4 demonstrated a dependence of cellular
responses on the matrix strain, suggesting functional control by cellular strain. In the
experiments of Chapters 5 and 6, the tensile biaxial strain device was used instead of the
gel culture compression configuration for several reasons. First, homogeneous and
biaxially uniform strain could be applied to cells. Second, both static and oscillatory
strains of varying frequencies were possible. Third, changes in morphology and cellular
injury could be microscopically detected.
Preliminary experiments demonstrated that FGF-2 and IL-1a, molecules which
lack secretory leader sequences, are released by cellular strain of smooth muscle cells and
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keratinocytes, respetively. The mechanical release of IL-la may be relevant to the
pathophysiology of psoriasis. Psoriasis is manifested primarily in extensor joint surfaces of
the extremities, and psoriatic symptoms are expressed by a transgenic mouse which over-
expresses IL-la. Further characterization of the FGF-2 release response revealed a strain-
amplitude threshold for both FGF-2 release and cell injury. In vivo, vessel wall dilation
typically does not exceed 5-10% suggesting that the amplitude-threshold for FGF-2
release may be a stringent requirement satisfied only during balloon angioplasty; however,
as discussed in Chapter 5, variations in tissue structure at the cellular level may result in a
sub-population of cells receiving strains higher than the macroscopic tissue strain. In
addition, structural heterogeneities in plaque may cause concentrations of strain.
Furthermore, random variations in intraluminal pressure may momentarily increase the
strains within some cells. As demonstrated by the experiments of Chapter 6, strain need
only exceed the amplitude-threshold for - 1 minute to induce maximal FGF-2 release. In
addition, FGF-2 release is limited and does not continue two hours after initiation of the
elevated strain. Once released, FGF-2 may be sequestered near the release site by the
low-affinity receptors. Thus, in certain vascular conditions, FGF-2 may be released from
smooth muscle cells in a temporally and spatially targeted fashion.
7.2 Limitations and Future Work
7.2.1 Integrins in Cellular Responses.
Although Chapter 2 demonstrated the role of collagen-specific integrins in
transmitting the forces from cell to matrix, force transmission and signal transduction from
matrix to cell may rely on different integrins. The mechanical induction of DNA synthesis
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via autocrine PDGF in vascular smooth muscle cells is mediated by fibronectin-specific
integrins 218 even when the cells are grown on collagen. Experiments imposing mechanical
strain to cells on various matrices in the presence of integrin-blocking antibodies and
peptides may clarify the role of integrins in FGF-2 release as well as other responses to
strain.
7.2.2 Growth Factor Responsiveness.
The experiments of Chapters 3 and 4 raise additional questions concerning the
regulation of cellular responses by mechanical loading. Although static compression
decreased DNA synthesis, and transient compression increased DNA synthesis, both forms
of loading should have similar effects on FGF-2 release. Assuming that FGF-2 is released
during sustained static compression, the differential response in DNA synthesis to static
and transient compression may suggest regulation of growth factor responsiveness by
strain. Experiments could be performed in both monolayer and three-dimensional matrix
culture to assess whether changes in cellular strain and/or matrix concentration (through
matrix compression) regulate cellular responses to exogenous growth factor.
7.2.3 Tissue Stress and Cellular Strain.
Although mechanical stress is commonly considered an important modulator of
biological function, under certain conditions, stress applied to a tissue may be an
insignificant parameter to a given cell. For example, dramatically elevated intravascular
pressure might not affect vascular smooth muscle cell function if the vessel wall
compliance is diminished. Interpretation of in vivo responses to mechanical stress might
require not only careful control of the stress, but also a knowledge of the tissue
compliance or the specific cellular strains. Altering the biaxial strain device to
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dynamically modulate the pressure of the culture medium might further clarify whether
bulk stress in addition to cellular strain independently regulates cell function. In the
absence of cellular deformation, changes in cellular function with ambient fluid pressure
would be surprising.
7.2. 4 Substrate Deformation and Cellular Strain.
The monolayer biaxial strain device in Chapter 5 was used in part to impose more
uniform cellular strains. Measured membrane strains were homogeneous and biaxially
uniform for dynamic deformations, and average cellular strains under static deformation
correlated with the predicted membrane strain. However, intracellular strains may deviate
from that of the underlying culture substrate depending on the number and distribution of
focal adhesions. 224 Additionally, the cellular strain behavior under dynamic membrane
deformation has yet to be characterized. The ability to continously observe cell
morphology during dynamic culture membrane deformation would be necessary to verify
the presumed correspondence between cellular and membrane strains.
7.2.5 Improving the Three-Dimensional Configuration.
Ultimately, the presence of a three-dimensional matrix may be important for
simulating certain in vivo cell-matrix interactions during mechanical loading. Compression
of the collagen gel culture was useful for studying responses to static and transient
loading, but was unsuitable for applying oscillatory deformations. In principle, the gel
culture could be adapted to a different configuration of mechanical loading to achieve
cyclic deformation.
171
7.2.6 Injury and IL-1 Release.
The experiments in Chapters 5 and 6 demonstrate the ability of mechanical strain
to release molecules (FGF-2 and IL-1) which lack secretory leader sequences. The mature
form of IL-1 is similar in size and tertiary structure to FGF-2, suggesting that both
molecules may be released from cells in a similar manner. Mechanical strain experiments
with other cells, particularly transfected cell lines with either the pro or mature forms of
IL-1 may elucidate the mechanism of release. One possible scenario may be that the
mature form of IL-1 is released preferentially over the pro-form due to size selection by
cell membrane disruption.
7.2.7 Other Responses.
Many of the experiments in this thesis may have been performed in a "high" strain
regime for these cells. Mechanical strain below the threshold for injury may control other
functions besides FGF-2 release. Additional experiments at lower strain levels may
elucidate the role of the mechanical environment in non-FGF-2-induced signal
transduction events and expression of immediate-early genes, 1s1' 236 chemotactic factors,'8
degradative enzymes, 37 and other mediators of atherosclerotic remodeling.
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